[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 1230
1. Jani N, Moser AJ, Khalid A: Pancreatic endocrine tumors. Gastroenterol Clin North Am; 2007 Jun;36(2):431-9, x-xi
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatic endocrine tumors.
  • Incidental, nonfunctional pancreatic endocrine tumors (PET) are observed with increasing frequency.
  • Endoscopic ultrasound with fine-needle aspiration plays a significant role in the localization and tissue diagnosis of PET.
  • Surgery is the mainstay of treating advanced disease including those with metastases and Zollinger-Ellison syndrome.
  • The management of multiple endocrine neoplasia type 1 continues to be a challenge, including treating symptoms, targeted resections, and close observation.
  • Diagnosis, management, and prognostication of PET are under evolution and a number of changes in these fronts are anticipated.
  • [MeSH-major] Neuroendocrine Tumors / diagnosis. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Diagnosis, Differential. Humans. Pancreatectomy. Prognosis

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17533088.001).
  • [ISSN] 0889-8553
  • [Journal-full-title] Gastroenterology clinics of North America
  • [ISO-abbreviation] Gastroenterol. Clin. North Am.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Number-of-references] 68
  •  go-up   go-down


2. Pfragner R, Behmel A, Höger H, Beham A, Ingolic E, Stelzer I, Svejda B, Moser VA, Obenauf AC, Siegl V, Haas O, Niederle B: Establishment and characterization of three novel cell lines - P-STS, L-STS, H-STS - derived from a human metastatic midgut carcinoid. Anticancer Res; 2009 Jun;29(6):1951-61
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mutation screening of P-STS excluded a MEN1-gene-associated genetic predisposition with high probability.
  • [MeSH-major] Carcinoid Tumor / pathology. Enterochromaffin Cells / pathology. Ileal Neoplasms / pathology. Lung Neoplasms / secondary


3. Miller BS, Rusinko RY, Fowler L: Synchronous thymoma and thymic carcinoid in a woman with multiple endocrine neoplasia type 1: case report and review. Endocr Pract; 2008 Sep;14(6):713-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Synchronous thymoma and thymic carcinoid in a woman with multiple endocrine neoplasia type 1: case report and review.
  • OBJECTIVE: To report a rare case of multiple endocrine neoplasia type 1 (MEN 1) in conjunction with concomitant thymoma and thymic carcinoid.
  • METHODS: We describe a never before reported case involving a 63-year-old female patient with MEN 1 who had synchronous thymoma and thymic carcinoid tumors.
  • RESULTS: Although prognosis is stage dependent for patients with thymoma, patients with thymic carcinoids and MEN 1 have been reported to have an extremely poor prognosis, with many patients dying of complications from thymic carcinoid rather than dying of other manifestations of MEN 1.
  • Our patient underwent successful surgical treatment and remains under surveillance for all aspects of the MEN 1 syndrome.
  • CONCLUSION: Thymic tumors are rare, and thymic carcinoids, while very rare in occurrence overall, have a definite association with MEN 1.
  • Thus, it is important for practitioners to screen for thymic tumors routinely in patients with MEN 1 and to treat such tumors aggressively when found because they can be a major cause of mortality.
  • Many thymic carcinoids are far advanced before diagnosis, and optimal screening for and treatment of thymic carcinoid are still being developed.
  • [MeSH-major] Carcinoid Tumor / diagnosis. Multiple Endocrine Neoplasia Type 1 / diagnosis. Thymoma / diagnosis. Thymus Neoplasms / diagnosis


Advertisement
4. Rindi G, Bordi C: Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics. Best Pract Res Clin Gastroenterol; 2005 Aug;19(4):519-34
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine tumours of the gastrointestinal tract: aetiology, molecular pathogenesis and genetics.
  • Endocrine tumours of the gut and pancreas originate from cells of the diffuse endocrine system and are characterised by the production of a wide variety of bioactive substances including growth factors.
  • Two major tumour categories are distinguished-well-differentiated and poorly differentiated neoplasms-with distinct phenotypes and significantly diverse clinical behaviour.
  • For well-differentiated tumours, independent techniques identified the abnormality of multiple chromosomal sites and genes, pointing to a complex genetic background.
  • The multiple endocrine neoplasia syndrome type 1 (MEN1) gene is reported to be involved in about one-third of sporadic foregut endocrine tumours and exceptionally in midgut and hindgut tumours.
  • [MeSH-major] Carcinoma, Neuroendocrine / genetics. Gastrointestinal Neoplasms / genetics. Pancreatic Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16183525.001).
  • [ISSN] 1521-6918
  • [Journal-full-title] Best practice & research. Clinical gastroenterology
  • [ISO-abbreviation] Best Pract Res Clin Gastroenterol
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / MEN1 protein, human; 0 / Proto-Oncogene Proteins; 0 / RASSF1 protein, human; 0 / Tumor Suppressor Proteins; 76057-06-2 / Transforming Growth Factors
  • [Number-of-references] 105
  •  go-up   go-down


5. Nakamura S: Type of motion in inverted self-motion perception induced by a foreground stimulus. Percept Mot Skills; 2006 Jun;102(3):899-904
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Type of motion in inverted self-motion perception induced by a foreground stimulus.
  • In this study, the effects of motion type of the foreground stimulus on inverted vection were investigated using a sample of 3 men and 1 woman.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16916170.001).
  • [ISSN] 0031-5125
  • [Journal-full-title] Perceptual and motor skills
  • [ISO-abbreviation] Percept Mot Skills
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


6. Marek B, Kajdaniuk D, Kos-Kudła B, Foltyn W, Borgiel-Marek H, Matyja V, Pakuła D: [Insulinoma--diagnosis and treatment]. Endokrynol Pol; 2007 Jan-Feb;58(1):58-62
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Insulinoma--diagnosis and treatment].
  • Insulinomas are the most common functioning endocrine tumors of pancreas.
  • Approximately 10% are multiple, less than 10% can be malignant and 5-10% associated with the MEN-1 syndrome.
  • The aim of this lecture is to present the up-to-date information concerning the prevalence, diagnosis and treatment of insulinoma.
  • [MeSH-major] Insulinoma. Multiple Endocrine Neoplasia Type 1. Pancreatic Neoplasms

  • Genetic Alliance. consumer health - Insulinoma.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17354206.001).
  • [ISSN] 0423-104X
  • [Journal-full-title] Endokrynologia Polska
  • [ISO-abbreviation] Endokrynol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 39
  •  go-up   go-down


7. Krause W, Rassner G, Happle R: ["Die grosse Barb" in the museum of the University of Marburg. An early documentation of acromegaly]. Hautarzt; 2009 Jun;60(6):502-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Acromegaly is a consequence of enhanced secretion of growth hormone, which occurs also as a symptom of several syndromes, such as multiple endocrine neoplasia type 1, McCune-Albright-syndrome, and NAME syndrome (Carney complex type I).
  • This occurs also in androgen-deficient states, such as the Klinefelter syndrome and some more genetic syndromes, of which the Simpson-Golabi-Behmel syndrome, the Sotos syndrome, the Marfan syndrome, the homocystinuria, and the fragile X-syndrome may be mentioned.

  • Genetic Alliance. consumer health - Acromegaly.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Dysmorphol. 2000 Jul;9(3):221-2 [10955485.001]
  • [Cites] J Am Acad Dermatol. 2003 Jun;48(6):962-5 [12789195.001]
  • [Cites] Horm Res. 2005;64(3):149-56 [16192740.001]
  • [Cites] J Med Genet. 1996 Nov;33(11):972-4 [8950682.001]
  • (PMID = 19543868.001).
  • [ISSN] 1432-1173
  • [Journal-full-title] Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete
  • [ISO-abbreviation] Hautarzt
  • [Language] ger
  • [Publication-type] English Abstract; Historical Article; Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


8. Thun MJ, Hannan LM, Adams-Campbell LL, Boffetta P, Buring JE, Feskanich D, Flanders WD, Jee SH, Katanoda K, Kolonel LN, Lee IM, Marugame T, Palmer JR, Riboli E, Sobue T, Avila-Tang E, Wilkens LR, Samet JM: Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med; 2008 Sep 30;5(9):e185
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • (1) Men had higher death rates from lung cancer than women in all age and racial groups studied;.
  • CONCLUSIONS: These comprehensive analyses support claims that the death rate from lung cancer among never-smokers is higher in men than in women, and in African Americans and Asians residing in Asia than in individuals of European descent, but contradict assertions that risk is increasing or that women have a higher incidence rate than men.
  • [MeSH-major] Lung Neoplasms / epidemiology. Registries. Smoking / epidemiology


9. Biçer M, Yanar M, Ercan A, Senkaya I: [Coronary-to-pulmonary artery fistulas: a report of three cases]. Turk Kardiyol Dern Ars; 2008 Jul;36(5):332-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • We presented three symptomatic patients (2 men, 1 woman; age range 46 to 53 years) who underwent surgical repair via the epicardial approach for coronary-to-pulmonary artery fistulas.
  • [MeSH-major] Coronary Disease / surgery. Coronary Vessel Anomalies / surgery. Fistula / surgery. Lung Diseases / surgery. Pulmonary Artery / abnormalities

  • MedlinePlus Health Information. consumer health - Fistulas.
  • MedlinePlus Health Information. consumer health - Lung Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18984986.001).
  • [ISSN] 1016-5169
  • [Journal-full-title] Türk Kardiyoloji Derneği arşivi : Türk Kardiyoloji Derneğinin yayın organıdır
  • [ISO-abbreviation] Turk Kardiyol Dern Ars
  • [Language] tur
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] Turkey
  •  go-up   go-down


10. Neill M, Studer G, Le L, McLean M, Yeung I, Pond G, Crook JM: The nature and extent of urinary morbidity in relation to prostate brachytherapy urethral dosimetry. Brachytherapy; 2007 Jul-Sep;6(3):173-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PURPOSE: This study investigates whether the location and dose of urethral radiation received during transperineal interstitial permanent prostate brachytherapy determine the degree and type of urinary symptoms experienced subsequently.
  • METHODS AND MATERIALS: Data from a prospectively acquired database of 219 men treated with transperineal interstitial permanent prostate brachytherapy using (125)I (prescribed dose 145Gy) between May 2001 and June 2003 were reviewed.
  • Catheterization was required for 28 men and was predicted by larger pretreatment transrectal ultrasound (TRUS) volume (OR 1.06 per unit change; 95% CI 1.03-1.10; p<0.001) and lower UV(150) (OR 0.30; 95% CI 0.13-0.68; p=0.004) in multivariate analysis.
  • Greater IPSS at baseline (p<0.001) and preoperative TRUS volume (p=0.012) but conversely smaller D(30) doses (p=0.003) were predictive of IPSS outcomes at 1 month.
  • IPSS returned to within two points of baseline for 72.2% of men by 1 year and 83.3% by 24 months.
  • This was predicted by higher IPSS at baseline (OR 6.0; 95% CI 2.72-13.22; p<0.001), higher D(30) (OR 1.17; 95% CI 1.01-1.36; p=0.031), and lower V(100) (OR 0.39; 95% CI 0.22-0.70; p=0.002).
  • [MeSH-major] Brachytherapy / methods. Prostatic Neoplasms / radiotherapy. Urethra / radiation effects. Urethral Stricture / epidemiology. Urination Disorders / epidemiology

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • MedlinePlus Health Information. consumer health - Urine and Urination.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17681239.001).
  • [ISSN] 1538-4721
  • [Journal-full-title] Brachytherapy
  • [ISO-abbreviation] Brachytherapy
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


11. Akagi R, Takai Y, Kato E, Wakahara T, Ohta M, Kanehisa H, Fukunaga T, Kawakami Y: Development of an equation to predict muscle volume of elbow flexors for men and women with a wide range of age. Eur J Appl Physiol; 2010 Mar;108(4):689-94
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Development of an equation to predict muscle volume of elbow flexors for men and women with a wide range of age.
  • The present study examined the age-related changes in muscle thickness (MT) and volume (MV) of elbow flexors and developed a prediction equation of the MV based on the MT applicable to men and women with a wide range of age.
  • The MT and MV were determined from a single ultrasonographic image and multiple magnetic resonance imaging scans, respectively, in 72 men and 75 women aged 19-77 year.
  • The subjects were randomly separated into either a validation (38 men and 42 women) or a cross-validation (34 men and 33 women) group, and a multiple regression equation to estimate MV using not only MT but also upper arm length (L), age and gender as independent variables [MV (cm(3)) = 60.8 x MT (cm) + 6.48 x L (cm) - 0.709 x age (year) + 51.4 x gender (0 women, 1 men) - 187.4] was validated and cross-validated.
  • Thus, the prediction equation for MV of elbow flexors newly developed was shown to be applicable to men and women with a wide range of age.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Acta Physiol Scand. 2001 Aug;172(4):249-55 [11531646.001]
  • [Cites] Int J Sports Med. 1994 Oct;15(7):420-5 [8002122.001]
  • [Cites] Eur J Appl Physiol. 2006 Jan;96(1):24-31 [16235068.001]
  • [Cites] Clin Physiol. 1989 Jun;9(3):207-20 [2743739.001]
  • [Cites] Lancet. 1986 Feb 8;1(8476):307-10 [2868172.001]
  • [Cites] J Gerontol A Biol Sci Med Sci. 2001 Oct;56(10):B443-8 [11584029.001]
  • [Cites] Age Ageing. 2009 Sep;38(5):564-9 [19596739.001]
  • [Cites] J Appl Physiol (1985). 1993 Jun;74(6):2740-4 [8365975.001]
  • [Cites] J Neurol Sci. 1998 Jul 15;159(1):60-6 [9700705.001]
  • [Cites] Eur J Appl Physiol. 2002 Jan;86(3):203-8 [11990727.001]
  • [Cites] J Biomech. 2007;40(11):2442-9 [17250841.001]
  • [Cites] Am J Hum Biol. 1994;6(2):161-170 [28548275.001]
  • [Cites] J Physiol. 1996 Oct 1;496 ( Pt 1):287-97 [8910216.001]
  • [Cites] Eur J Appl Physiol. 2000 Aug;82(5-6):391-6 [10985592.001]
  • [Cites] J Gerontol. 1990 Sep;45(5):M175-9 [2394914.001]
  • [Cites] J Appl Physiol (1985). 1999 May;86(5):1670-5 [10233134.001]
  • [Cites] J Appl Physiol (1985). 2001 Sep;91(3):1341-9 [11509534.001]
  • [Cites] Eur J Appl Physiol. 2004 Mar;91(2-3):264-72 [14569399.001]
  • [Cites] J Strength Cond Res. 2008 Jan;22(1):82-7 [18296959.001]
  • (PMID = 19904555.001).
  • [ISSN] 1439-6327
  • [Journal-full-title] European journal of applied physiology
  • [ISO-abbreviation] Eur. J. Appl. Physiol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Validation Studies
  • [Publication-country] Germany
  •  go-up   go-down


12. Taïeb D, Sebag F, Barlier A, Tessonnier L, Palazzo FF, Morange I, Niccoli-Sire P, Fakhry N, De Micco C, Cammilleri S, Enjalbert A, Henry JF, Mundler O: 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? J Nucl Med; 2009 May;50(5):711-7
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Twenty-eight consecutive unrelated patients with chromaffin tumors, including 9 patients with genetically determined disease, were studied.
  • A combination of preoperative imaging work-up, surgical findings, and pathologic analyses was used to classify the patients into 2 groups: those with nonmetastatic disease (presumed benign, n = 18) and those with metastatic tumors (n = 10). (18)F-FDG PET was performed in all cases.
  • Succinate dehydrogenase and Von-Hippel Lindau-related tumors had a significantly higher SUVmax than did neurofibromatosis type 1 and multiple endocrine neoplasia type 2A syndrome-related tumors (P = 0.02). (18)F-FDG PET was superior to (131)I-metaiodobenzylguanidine in all metastatic patients but one.
  • By contrast, (18)F-FDG PET underestimated the extent of the disease, compared with 6-(18)F-fluorodopa PET, in 5 patients with metastatic pheochromocytoma.

  • MedlinePlus Health Information. consumer health - Pheochromocytoma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19372492.001).
  • [ISSN] 0161-5505
  • [Journal-full-title] Journal of nuclear medicine : official publication, Society of Nuclear Medicine
  • [ISO-abbreviation] J. Nucl. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 0Z5B2CJX4D / Fluorodeoxyglucose F18; EC 1.3.99.1 / Succinate Dehydrogenase
  •  go-up   go-down


13. Novotny E, Compton S, Liu PP, Collins FS, Chandrasekharappa SC: In vitro hematopoietic differentiation of mouse embryonic stem cells requires the tumor suppressor menin and is mediated by Hoxa9. Mech Dev; 2009 Jul;126(7):517-22
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Inactivating mutations in the tumor suppressor gene MEN1 cause the inherited cancer syndrome multiple endocrine neoplasia type 1 (MEN1).
  • The ubiquitously expressed MEN1 encoded protein, menin, interacts with MLL (mixed-lineage leukemia protein), and together they are essential components of a multiprotein complex with histone methyl transferase activity.
  • We generated Men1(-/-) embryonic stem (ES) cell lines, and induced them to differentiate in vitro.
  • The Men1(-/-) ES cells show reduced expression of Hoxa9 that can be recovered by reexpression of Menin.
  • We demonstrate that the block in differentiation of Men1(-/-) ES cell lines can be rescued not only by the expression of menin but also that of Hoxa9.

  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1118-23 [11158604.001]
  • [Cites] Blood. 2009 Feb 19;113(8):1661-9 [19228930.001]
  • [Cites] Genes Dev. 2003 Sep 15;17(18):2298-307 [12952893.001]
  • [Cites] Mol Cell. 2004 Feb 27;13(4):587-97 [14992727.001]
  • [Cites] Dev Cell. 2004 Mar;6(3):437-43 [15030765.001]
  • [Cites] Mol Cell Biol. 2004 Jul;24(13):5639-49 [15199122.001]
  • [Cites] Cell. 1996 Nov 15;87(4):687-96 [8929537.001]
  • [Cites] Science. 1997 Apr 18;276(5311):404-7 [9103196.001]
  • [Cites] Development. 1997 May;124(10):2039-48 [9169850.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1630-4 [9465067.001]
  • [Cites] Curr Biol. 2004 Nov 23;14(22):2063-9 [15556871.001]
  • [Cites] Nat Rev Cancer. 2005 May;5(5):367-75 [15864278.001]
  • [Cites] Cell. 2005 Oct 21;123(2):207-18 [16239140.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1018-23 [16415155.001]
  • [Cites] Blood. 2006 Jul 1;108(1):297-304 [16507773.001]
  • [Cites] Cancer Res. 2007 Aug 1;67(15):7275-83 [17671196.001]
  • [Cites] Blood Cells Mol Dis. 2008 Mar-Apr;40(2):156-9 [17916434.001]
  • [Cites] Leukemia. 2008 Jun;22(6):1161-9 [18337761.001]
  • [Cites] J Intern Med. 2003 Jun;253(6):606-15 [12755956.001]
  • (PMID = 19393316.001).
  • [ISSN] 1872-6356
  • [Journal-full-title] Mechanisms of development
  • [ISO-abbreviation] Mech. Dev.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 HG000029-13
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Homeodomain Proteins; 0 / Men1 protein, mouse; 0 / Proto-Oncogene Proteins; 0 / Tumor Suppressor Proteins; 0 / homeobox protein HOXA9
  • [Other-IDs] NLM/ NIHMS111099; NLM/ PMC2717021
  •  go-up   go-down


14. Agarwal SK, Kennedy PA, Scacheri PC, Novotny EA, Hickman AB, Cerrato A, Rice TS, Moore JB, Rao S, Ji Y, Mateo C, Libutti SK, Oliver B, Chandrasekharappa SC, Burns AL, Collins FS, Spiegel AM, Marx SJ: Menin molecular interactions: insights into normal functions and tumorigenesis. Horm Metab Res; 2005 Jun;37(6):369-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multiple endocrine neoplasia type 1 (MEN1) is an autosomal dominant disease predisposed by heterozygous germline mutations in the MEN1 tumor suppressor gene.
  • Biallelic loss of MEN1 resulting from small mutation and/or loss of heterozygosity occurs in a large tissue spectrum of MEN1 tumors or non-hereditary tumors.
  • Mouse models of MEN1 underexpression or overexpression have also supported the tumor-suppressor effect of the MEN1 gene.
  • Menin, the 610-amino-acid protein encoded by MEN1, is expressed ubiquitously and found predominantly in the nucleus.
  • The diverse functions of menin interactors suggest roles for menin in multiple biological pathways.
  • [MeSH-major] Gene Expression Regulation, Neoplastic. Multiple Endocrine Neoplasia Type 1 / metabolism. Proto-Oncogene Proteins / metabolism

  • Genetics Home Reference. consumer health - MEN1 gene.
  • COS Scholar Universe. author profiles.
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16001329.001).
  • [ISSN] 0018-5043
  • [Journal-full-title] Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme
  • [ISO-abbreviation] Horm. Metab. Res.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Cytoskeletal Proteins; 0 / MEN1 protein, human; 0 / Proto-Oncogene Proteins; 0 / Transcription Factors; 9007-49-2 / DNA
  • [Number-of-references] 57
  •  go-up   go-down


15. Wilson SD, Krzywda EA, Zhu YR, Yen TW, Wang TS, Sugg SL, Pappas SG: The influence of surgery in MEN-1 syndrome: observations over 150 years. Surgery; 2008 Oct;144(4):695-701; discussion 701-2
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The influence of surgery in MEN-1 syndrome: observations over 150 years.
  • BACKGROUND: Efficacy and timing of operative intervention in patients with multiple endocrine neoplasia type 1 (MEN-1) syndrome remains controversial.
  • This report utilizes a novel approach to evaluate the influence of evolving operative interventions for patients with MEN-1 syndrome.
  • METHODS: Six generations from a large MEN-1 family pedigree were studied.
  • The number of operations for MEN-1 related pathology was recorded according to birth eras over 150 years.
  • RESULTS: Inheritance of the MEN-1 trait was near 50%.
  • Death occurred >20 years earlier in MEN-1 individuals than unaffected family members in eras 1 and 2.
  • Family members with MEN-1 lived longer in succeeding eras with increasing number of operative and pharmacologic interventions.
  • CONCLUSION: MEN-1 family members invariably have pathologic changes in pituitary, parathyroid, and pancreatic islets when long lived, the "all-or-none" phenomenon.
  • This model may allow better comparisons with other MEN-1 patients when evaluating outcomes of new medical and operative management schemes and long-term follow-up.
  • [MeSH-major] Cause of Death. Genetic Predisposition to Disease / epidemiology. Multiple Endocrine Neoplasia Type 1 / mortality. Multiple Endocrine Neoplasia Type 1 / surgery. Surgical Procedures, Operative / methods
  • [MeSH-minor] Adult. Age Distribution. Aged. Aged, 80 and over. Cohort Studies. Female. Follow-Up Studies. Humans. Male. Middle Aged. Pancreatic Neoplasms / genetics. Pancreatic Neoplasms / mortality. Pancreatic Neoplasms / surgery. Parathyroid Neoplasms / genetics. Parathyroid Neoplasms / mortality. Parathyroid Neoplasms / surgery. Pedigree. Pituitary Neoplasms / genetics. Pituitary Neoplasms / mortality. Pituitary Neoplasms / surgery. Registries. Retrospective Studies. Risk Assessment. Sex Distribution. Survival Analysis. Syndrome. Time Factors. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Surgery.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18847656.001).
  • [ISSN] 1532-7361
  • [Journal-full-title] Surgery
  • [ISO-abbreviation] Surgery
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


16. Goodreau SM, Goicochea LP, Sanchez J: Sexual role and transmission of HIV Type 1 among men who have sex with men, in Peru. J Infect Dis; 2005 Feb 1;191 Suppl 1:S147-58
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sexual role and transmission of HIV Type 1 among men who have sex with men, in Peru.
  • In Latin America, men who have sex with men (MSM) have traditionally practiced role segregation--that is, the adoption of a fixed role (insertive or receptive) rather than a versatile role (both practices) during anal sex.
  • Previous modeling has shown that role segregation may yield a lower incidence of human immunodeficiency virus (HIV) type 1 infection, compared with role versatility; however, the modeling assumed no risk of acquiring HIV-1 during insertive sex, which is now recognized as unlikely.

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • COS Scholar Universe. author profiles.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15627225.001).
  • [ISSN] 0022-1899
  • [Journal-full-title] The Journal of infectious diseases
  • [ISO-abbreviation] J. Infect. Dis.
  • [Language] ENG
  • [Grant] None / None / / R24 HD042828-10; United States / NIAID NIH HHS / AI / U01 AI047981; United States / NICHD NIH HHS / HD / R24 HD042828-10; United States / NIDA NIH HHS / DA / R01 DA012831; United States / NIAID NIH HHS / AI / T32 AI007140; United States / NIAID NIH HHS / AI / U01-AI47981; United States / NIAID NIH HHS / AI / T32-AI07140; United States / FIC NIH HHS / TW / D43-TW0000715; United States / NICHD NIH HHS / HD / R01-HD34957; United States / NIDA NIH HHS / DA / R01-DA012831; United States / NICHD NIH HHS / HD / R01 HD041877; United States / NICHD NIH HHS / HD / R24 HD042828
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS313234; NLM/ PMC4063354
  •  go-up   go-down


17. Vierhapper H, Heinze G, Nowotny P: Sex-specific difference in the interconversion of cortisol and cortisone in men and women. Obesity (Silver Spring); 2007 Apr;15(4):820-4
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Sex-specific difference in the interconversion of cortisol and cortisone in men and women.
  • OBJECTIVE: Our objective was to demonstrate that the smaller oxoreductase activity of 11beta-HSD1 in women would shift the interconversion of cortisol and cortisone toward cortisone, resulting in a larger amount of generated labeled cortisone in healthy women than in healthy men.
  • RESEARCH METHODS AND PROCEDURES: Using mass spectrometry, the amount of cortisone generated from a continuous infusion (8 am to 6 pm) of stable-labeled cortisol (1alpha,2alpha-d-cortisol) was determined in non-obese and in obese (BMI>35 kg/m2) men and women during steady-state conditions (from 2 pm to 6 pm).
  • RESULTS: The amount of generated labeled cortisone was higher in men than in women (p<0.0001).
  • CONCLUSIONS: The interconversion of cortisol and cortisone during steady-state conditions is shifted toward cortisol in men as compared with women.
  • This suggests a higher overall oxoreductase activity of 11beta-hydroxysteroid dehydrogenase type 1 in men than in women.
  • [MeSH-minor] 11-beta-Hydroxysteroid Dehydrogenase Type 1 / blood. Adult. Body Mass Index. Chromatography, Liquid. Female. Gas Chromatography-Mass Spectrometry / methods. Humans. Ions. Male. Sex Factors. Tetrahydrocortisol / urine. Tetrahydrocortisone / urine

  • MedlinePlus Health Information. consumer health - Obesity.
  • Hazardous Substances Data Bank. HYDROCORTISONE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17426315.001).
  • [ISSN] 1930-7381
  • [Journal-full-title] Obesity (Silver Spring, Md.)
  • [ISO-abbreviation] Obesity (Silver Spring)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Ions; 5HF9TM2D15 / Tetrahydrocortisone; 7P2O6MFN8O / Tetrahydrocortisol; EC 1.1.1.146 / 11-beta-Hydroxysteroid Dehydrogenase Type 1; V27W9254FZ / Cortisone; WI4X0X7BPJ / Hydrocortisone
  •  go-up   go-down


18. Clemente G, Sarno G, Giordano M, De Rose AM, Giovannini I, Vecchio FM, Nuzzo G: Total gastrectomy for type 1 gastric carcinoid: an unusual surgical indication? Minerva Chir; 2007 Oct;62(5):421-4
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Total gastrectomy for type 1 gastric carcinoid: an unusual surgical indication?
  • Gastric carcinoids are divided into three different types: Type 1, associated with gastric atrophy and megaloblastic anemia; Type 2, associated with Zollinger-Ellison syndrome within a type 1 multiple endocrine neoplasia (MEN); and Type 3, sporadic tumor not associated with other lesions, particularly invasive and with poor prognosis.
  • Type 1 carcinoid is usually asymptomatic and casually detected at endoscopy due to aspecific symptoms or to screening in patients with atrophic gastritis.
  • We report a case of a woman with a type 1 gastric carcinoid in which, for the presence of an extended micro-polyposis of the fundus a total gastrectomy was necessary for treatment.
  • In conclusion this finding, unknown before surgery, emphasizes the need for careful assessment also in the presence of apparently less important gastric carcinoid lesions.
  • [MeSH-major] Carcinoid Tumor / surgery. Gastrectomy. Stomach Neoplasms / pathology. Stomach Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17947953.001).
  • [ISSN] 0026-4733
  • [Journal-full-title] Minerva chirurgica
  • [ISO-abbreviation] Minerva Chir
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Italy
  •  go-up   go-down


19. Krysiak R, Okopień B, Herman ZS: [Rare pancreatic endocrine tumors]. Przegl Lek; 2008;65(4):209-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Rare pancreatic endocrine tumors].
  • Functional pancreatic endocrine tumors other than gastrinoma and insulinoma are quite rare.
  • Some of these tumors may be part of multiple endocrine neoplasia type one (MEN-1) syndrome or phakomatoses.
  • Depending on their cell type, functional pancreatic endocrine tumors may cause distinct clinical endocrine syndromes, such as the 'glucagonoma syndrome', Verner-Morrison syndrome and the 'somatostatinoma syndrome'.
  • The significant progress made in recent years, especially in the field of imaging procedures, has brought about great improvement in the identification and differentiation of these neoplasms.
  • The medical treatment of endocrine pancreatic tumours consists of somatostatin analogues, chemotherapy, and interferon-alpha.
  • The purpose of this manuscript is to provide an overview of the contemporary etiopathogenesis, diagnosis and treatment of rare pancreatic endocrine tumors.
  • [MeSH-major] Glucagonoma / diagnosis. Glucagonoma / therapy. Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / therapy. Somatostatinoma / diagnosis. Somatostatinoma / therapy. Vipoma / diagnosis. Vipoma / therapy
  • [MeSH-minor] Humans. Rare Diseases / diagnosis. Rare Diseases / therapy

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18724549.001).
  • [ISSN] 0033-2240
  • [Journal-full-title] Przegla̧d lekarski
  • [ISO-abbreviation] Prz. Lek.
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 47
  •  go-up   go-down


20. Simon R, Tschopp JM: [Obstructive sleep apnoea syndrome]. Rev Med Suisse; 2005 Jun 8;1(23):1556-60
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Obstructive sleep apnoea syndrome].
  • [Transliterated title] Syndrome d'apnées du sommeil, une pathologie fréquente encore insuffisamment diagnostiquée.
  • Sleep apnoea syndrome is a frequent disease, occurring in men aged more than 30 years and in postmenopaused women.
  • Its prevalence is more than 1% in men and between 0,3%-0,5% in women.
  • Diagnosis is made by polysomnography, which is considered as a gold standard, or by polygraphy.
  • Sleep apnoea syndrome must be looked for by clinicians in presence of symptoms such as sleepiness, snoring, or behavioural problems, because these patients have a high risk not only of driving crashes, but also of arterial hypertension, brain strokes, and myocardial infarction, without treatment.
  • [MeSH-major] Cardiovascular Diseases / etiology. Polysomnography. Sleep Apnea, Obstructive / complications. Sleep Apnea, Obstructive / diagnosis

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16044797.001).
  • [ISSN] 1660-9379
  • [Journal-full-title] Revue médicale suisse
  • [ISO-abbreviation] Rev Med Suisse
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Switzerland
  • [Number-of-references] 34
  •  go-up   go-down


21. Sharretts JM, Simonds WF: Clinical and molecular genetics of parathyroid neoplasms. Best Pract Res Clin Endocrinol Metab; 2010 Jun;24(3):491-502
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Clinical and molecular genetics of parathyroid neoplasms.
  • While most HPT is sporadic, it is associated with a familial syndrome in a minority of cases.
  • The study of these syndromes has helped define the pathophysiology of both familial and sporadic parathyroid neoplasms.
  • Investigation of kindred with multiple endocrine neoplasia type 1 (MEN1) and the hyperparathyroidism-jaw tumour syndrome (HPT-JT) led to the discovery of the tumour suppressor genes MEN1 and HRPT2.
  • We now recognise that somatic mutations in MEN1 and HRPT2 tumour suppressor genes are frequent events in sporadic parathyroid adenomas and carcinomas, respectively.
  • Parathyroid tumours in the MEN2A syndrome result from mutational activation of the RET oncogene.
  • Studies of familial isolated HPT and analysis of chromosomal loss and gain in parathyroid tumours suggest that other genes relevant to parathyroid neoplasia await identification.
  • [MeSH-major] Hyperparathyroidism, Primary / genetics. Parathyroid Neoplasms / genetics
  • [MeSH-minor] Female. Humans. Male. Multiple Endocrine Neoplasia Type 1 / genetics. Multiple Endocrine Neoplasia Type 1 / pathology. Parathyroid Hormone / genetics. Proto-Oncogene Proteins c-ret / genetics. Tumor Suppressor Proteins / genetics

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Published by Elsevier Ltd.
  • [Cites] Adv Anat Pathol. 2009 Jan;16(1):23-32 [19098464.001]
  • [Cites] J Clin Endocrinol Metab. 2009 May;94(5):1826-34 [19141585.001]
  • [Cites] J Intern Med. 2009 Jul;266(1):84-98 [19522828.001]
  • [Cites] Lancet. 2009 Jul 11;374(9684):145-58 [19595349.001]
  • [Cites] Mol Cell Endocrinol. 2009 Dec 10;313(1-2):1-8 [19729047.001]
  • [Cites] World J Surg. 2009 Nov;33(11):2224-33 [19373510.001]
  • [Cites] J Endocrinol Invest. 2009 Jun;32(6):512-8 [19474519.001]
  • [Cites] Endocr Pract. 2009 Sep-Oct;15(6):567-72 [19491073.001]
  • [Cites] J Clin Endocrinol Metab. 2009 Nov;94(11):4372-9 [19789209.001]
  • [Cites] Endocr Relat Cancer. 2009 Dec;16(4):1313-27 [19620250.001]
  • [Cites] Endocr Relat Cancer. 2010 Mar;17(1):135-46 [19926710.001]
  • [Cites] Eur J Endocrinol. 2000 Jul;143(1):47-54 [10870030.001]
  • [Cites] Am J Pathol. 2000 Aug;157(2):579-86 [10934160.001]
  • [Cites] Hum Mutat. 2000 Oct;16(4):281-96 [11013439.001]
  • [Cites] Cancer Res. 2000 Oct 1;60(19):5553-7 [11034102.001]
  • [Cites] Endocrinol Metab Clin North Am. 2000 Sep;29(3):503-22 [11033758.001]
  • [Cites] N Engl J Med. 2000 Dec 21;343(25):1863-75 [11117980.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1118-23 [11158604.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Mar 27;98(7):3837-42 [11274402.001]
  • [Cites] Am J Pathol. 2001 Apr;158(4):1355-62 [11290553.001]
  • [Cites] Trends Endocrinol Metab. 2001 May-Jun;12(4):173-8 [11295574.001]
  • [Cites] Cancer Lett. 2002 Jan 25;175(2):175-9 [11741745.001]
  • [Cites] Medicine (Baltimore). 2002 Jan;81(1):1-26 [11807402.001]
  • [Cites] Eur J Endocrinol. 2002 Feb;146(2):209-13 [11834430.001]
  • [Cites] Clin Endocrinol (Oxf). 2002 Apr;56(4):457-64 [11966738.001]
  • [Cites] Endocr Pathol. 2002 Spring;13(1):3-16 [12114746.001]
  • [Cites] Mayo Clin Proc. 2002 Aug;77(8):866-9 [12173721.001]
  • [Cites] Am J Pathol. 2002 Oct;161(4):1299-306 [12368203.001]
  • [Cites] Nat Genet. 2002 Dec;32(4):676-80 [12434154.001]
  • [Cites] J Intern Med. 2003 Jun;253(6):634-42 [12755959.001]
  • [Cites] Cell. 2003 Jun 27;113(7):881-9 [12837246.001]
  • [Cites] J Med Genet. 2003 Sep;40(9):657-63 [12960210.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10770-5 [12960363.001]
  • [Cites] Cancer Res. 2003 Oct 1;63(19):6135-9 [14559791.001]
  • [Cites] N Engl J Med. 2003 Oct 30;349(18):1722-9 [14585940.001]
  • [Cites] Cancer Res. 2003 Nov 15;63(22):8022-8 [14633735.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Jan;89(1):96-102 [14715834.001]
  • [Cites] J Med Genet. 2004 Mar;41(3):155-60 [14985373.001]
  • [Cites] J Med Genet. 2004 Mar;41(3):e32 [14985403.001]
  • [Cites] Mol Cell. 2004 Feb 27;13(4):587-97 [14992727.001]
  • [Cites] Cancer Res. 2004 Mar 15;64(6):2222-8 [15026366.001]
  • [Cites] Mol Cell Biol. 2004 Jul;24(13):5639-49 [15199122.001]
  • [Cites] Cancer Res. 2004 Sep 15;64(18):6791-6 [15374998.001]
  • [Cites] Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3 [5279523.001]
  • [Cites] Medicine (Baltimore). 1981 Nov;60(6):397-412 [7311809.001]
  • [Cites] Am J Med. 1985 Mar;78(3):467-74 [2858157.001]
  • [Cites] J Clin Invest. 1989 Jun;83(6):2034-40 [2723071.001]
  • [Cites] Surgery. 1990 Dec;108(6):1006-12; discussion 1012-3 [2123361.001]
  • [Cites] Oncogene. 1991 Mar;6(3):449-53 [2011400.001]
  • [Cites] Nature. 1991 Apr 11;350(6318):512-5 [1826542.001]
  • [Cites] Medicine (Baltimore). 1992 Jul;71(4):197-205 [1518393.001]
  • [Cites] Am J Hum Genet. 1993 Jul;53(1):193-200 [8317484.001]
  • [Cites] Cell. 1993 Dec 31;75(7):1297-303 [7916660.001]
  • [Cites] J Clin Endocrinol Metab. 1995 Jan;80(1):254-7 [7829622.001]
  • [Cites] N Engl J Med. 1995 Jul 27;333(4):234-40 [7791841.001]
  • [Cites] Cancer Lett. 1995 Jul 13;93(2):165-70 [7621424.001]
  • [Cites] J Clin Endocrinol Metab. 1995 Nov;80(11):3107-10 [7593409.001]
  • [Cites] J Clin Endocrinol Metab. 1996 May;81(5):1736-9 [8626826.001]
  • [Cites] JAMA. 1996 Nov 20;276(19):1575-9 [8918855.001]
  • [Cites] Science. 1997 Apr 18;276(5311):404-7 [9103196.001]
  • [Cites] Hum Mol Genet. 1997 Jul;6(7):1169-75 [9215689.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Oct;82(10):3481-6 [9329389.001]
  • [Cites] J Clin Endocrinol Metab. 1998 May;83(5):1766-70 [9589690.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Aug;83(8):2627-30 [9709922.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Aug;83(8):2960-3 [9709976.001]
  • [Cites] Cancer Genet Cytogenet. 1998 Oct 1;106(1):30-6 [9772906.001]
  • [Cites] Surgery. 1998 Dec;124(6):993-9 [9854574.001]
  • [Cites] Am J Hum Genet. 1999 Jan;64(1):189-95 [9915958.001]
  • [Cites] Cell. 1999 Jan 8;96(1):143-52 [9989505.001]
  • [Cites] Kidney Int. 1999 Apr;55(4):1375-83 [10201002.001]
  • [Cites] Mod Pathol. 1999 Apr;12(4):412-6 [10229506.001]
  • [Cites] J Bone Miner Res. 1999 Jun;14(6):878-82 [10352095.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Oct;84(10):3775-80 [10523029.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Nov;89(11):5583-91 [15531515.001]
  • [Cites] J Intern Med. 2005 Jan;257(1):18-26 [15606373.001]
  • [Cites] Mol Cell Biol. 2005 Jan;25(2):612-20 [15632063.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):749-54 [15640349.001]
  • [Cites] Crit Rev Clin Lab Sci. 2005;42(1):35-70 [15697170.001]
  • [Cites] Adv Anat Pathol. 2005 Mar;12(2):53-61 [15731573.001]
  • [Cites] Otolaryngol Head Neck Surg. 2005 Mar;132(3):359-72 [15746845.001]
  • [Cites] J Endocrinol Invest. 2004 Dec;27(11):1015-21 [15754732.001]
  • [Cites] Nat Rev Cancer. 2005 May;5(5):367-75 [15864278.001]
  • [Cites] J Clin Endocrinol Metab. 2005 Sep;90(9):5015-7 [15956079.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14659-64 [16195383.001]
  • [Cites] Clin Endocrinol (Oxf). 2006 Feb;64(2):146-52 [16430712.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Jan 24;103(4):1018-23 [16415155.001]
  • [Cites] J Med Genet. 2006 Mar;43(3):e12 [16525030.001]
  • [Cites] Cancer Res. 2006 Sep 1;66(17):8397-403 [16951149.001]
  • [Cites] Proc Natl Acad Sci U S A. 2006 Oct 17;103(42):15558-63 [17030811.001]
  • [Cites] J Clin Endocrinol Metab. 2006 Dec;91(12):5019-21 [17003089.001]
  • [Cites] Mol Cancer Res. 2007 Feb;5(2):183-93 [17314275.001]
  • [Cites] Hum Mutat. 2008 Jan;29(1):22-32 [17879353.001]
  • [Cites] Endocr Relat Cancer. 2008 Mar;15(1):267-75 [18310293.001]
  • [Cites] Mol Cell Biol. 2008 May;28(9):2930-40 [18212049.001]
  • [Cites] Genes Chromosomes Cancer. 2008 Aug;47(8):639-48 [18398822.001]
  • [Cites] Cancer Cell. 2008 Jul 8;14(1):36-46 [18598942.001]
  • [Cites] Mol Cancer. 2008;7:65 [18687124.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Nov 11;105(45):17420-5 [18987311.001]
  • [Cites] J Bone Miner Res. 2009 Jan;24(1):102-4 [18767934.001]
  • (PMID = 20833339.001).
  • [ISSN] 1878-1594
  • [Journal-full-title] Best practice & research. Clinical endocrinology & metabolism
  • [ISO-abbreviation] Best Pract. Res. Clin. Endocrinol. Metab.
  • [Language] eng
  • [Grant] United States / Intramural NIH HHS / / Z01 DK043012-06
  • [Publication-type] Journal Article; Research Support, N.I.H., Intramural; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / CDC73 protein, human; 0 / Parathyroid Hormone; 0 / Tumor Suppressor Proteins; EC 2.7.10.1 / Proto-Oncogene Proteins c-ret; EC 2.7.10.1 / RET protein, human
  • [Other-IDs] NLM/ NIHMS172037; NLM/ PMC2939004
  •  go-up   go-down


22. Okauchi Y, Nammo T, Iwahashi H, Kizu T, Hayashi I, Okita K, Yamagata K, Uno S, Katsube F, Matsuhisa M, Kato K, Aozasa K, Kim T, Osuga K, Nakamori S, Tamaki Y, Funahashi T, Miyagawa J, Shimomura I: Glucagonoma diagnosed by arterial stimulation and venous sampling (ASVS). Intern Med; 2009;48(12):1025-30
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • To identify the location of pancreatic endocrine tumors, arterial stimulation and venous sampling (ASVS) is known to be useful for insulinoma and gastrinoma, but its usefulness for glucagonoma has not been verified to date.
  • MEN1 gene analysis verified the presence of a mutation and the glucagonoma was confirmed after operation.
  • In conclusion, ASVS could be useful for the diagnosis of glucagonoma.
  • [MeSH-major] Glucagon / blood. Glucagonoma / diagnosis. Pancreatic Neoplasms / diagnosis
  • [MeSH-minor] Aged. Calcium / pharmacology. Female. Humans. Multiple Endocrine Neoplasia Type 1 / genetics. Mutation / genetics

  • Genetic Alliance. consumer health - Glucagonoma.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • Hazardous Substances Data Bank. GLUCAGON .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19525592.001).
  • [ISSN] 1349-7235
  • [Journal-full-title] Internal medicine (Tokyo, Japan)
  • [ISO-abbreviation] Intern. Med.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 9007-92-5 / Glucagon; SY7Q814VUP / Calcium
  •  go-up   go-down


23. Wenzel JJ, Rossmann H, Lackner KJ, Musholt TJ: Novel human pathological mutations. Gene symbol: MEN1. Disease: MEN1, Multiple endocrine neoplasia, type 1. Hum Genet; 2007 Nov;122(3-4):416
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Novel human pathological mutations. Gene symbol: MEN1. Disease: MEN1, Multiple endocrine neoplasia, type 1.
  • [MeSH-major] Multiple Endocrine Neoplasia Type 1 / genetics. Proto-Oncogene Proteins / genetics


24. Prayson RA, Yoder BJ: Clinicopathologic findings in mesial temporal sclerosis treated with gamma knife radiotherapy. Ann Diagn Pathol; 2007 Feb;11(1):22-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The study group is composed of 4 patients (3 women, 1 men) with ages 55, 48, 22, and 20 years, respectively, at the time of GKR.
  • Imaging studies, electroencephalogram, and surgical specimens all confirmed the diagnosis of MTS.

  • MedlinePlus Health Information. consumer health - Brain Diseases.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17240303.001).
  • [ISSN] 1092-9134
  • [Journal-full-title] Annals of diagnostic pathology
  • [ISO-abbreviation] Ann Diagn Pathol
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


25. Zhou H, Schweikert HU, Wolff M, Fischer HP: Primary peripancreatic lymph node gastrinoma in a woman with MEN1. J Hepatobiliary Pancreat Surg; 2006;13(5):477-81
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary peripancreatic lymph node gastrinoma in a woman with MEN1.
  • A 39-year-old woman was admitted to hospital due to perforated relapsing duodenal ulcer.
  • Clinical, laboratory, and surgical examinations revealed a peripancreatic lymph node gastrinoma as the cause of Zollinger-Ellison syndrome.
  • Further examinations established multiple endocrine neoplasia type 1 (MEN1) with a germline mutation at codon 1153 (T->A) in exon 7, causing an amino-acid change, from isoleucine to asparagine (Ile348Asn), in the MEN1 gene.
  • The following findings strongly supported a diagnosis of primary lymph node gastrinoma: a rapid fall of the serum gastrin level after operation, the continuous normalization of the serum gastrin level before and after secretin stimulation, the lack of any symptoms, and the absence of another tumor for 13 years after surgical resection of the tumor-bearing lymph node.
  • A long-term symptom-free follow-up after the excision of a lymphnode gastrinoma is the only reliable criterion for the diagnosis of a primary lymph node tumor.
  • To our knowledge, this is the only well-documented case of a primary lymph node gastrinoma in a patient with MEN1.
  • Our case supports the idea that any gastrinoma in patients with MEN1 should be surgically resected for cure if possible.
  • [MeSH-major] Lymphoma / pathology. Multiple Endocrine Neoplasia Type 1 / pathology
  • [MeSH-minor] Adult. Female. Gastrinoma. Humans. Pancreas. Zollinger-Ellison Syndrome / pathology

  • MedlinePlus Health Information. consumer health - Lymphoma.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17013727.001).
  • [ISSN] 0944-1166
  • [Journal-full-title] Journal of hepato-biliary-pancreatic surgery
  • [ISO-abbreviation] J Hepatobiliary Pancreat Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Review
  • [Publication-country] Japan
  • [Number-of-references] 39
  •  go-up   go-down


26. Bernstein KT, Stephens SC, Barry PM, Kohn R, Philip SS, Liska S, Klausner JD: Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men. Clin Infect Dis; 2009 Dec 15;49(12):1793-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Chlamydia trachomatis and Neisseria gonorrhoeae transmission from the oropharynx to the urethra among men who have sex with men.
  • We examined urethral C. trachomatis and N. gonorrhoeae positivity among men who have sex with men (MSM) seen at San Francisco City Clinic (San Francisco, CA) during 2007.
  • METHODS: All patients who sought care at the San Francisco City Clinic (the only municipal sexually transmitted disease clinic in San Francisco) received a standardized interview conducted by clinicians.
  • (1) men who reported their only urethral exposure was receiving fellatio in the previous 3 months and (2) men who reported unprotected insertive anal sex in the previous 3 months.

  • Genetic Alliance. consumer health - Chlamydia.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Clin Infect Dis. 2009 Dec 15;49(12):1798-800 [19911969.001]
  • (PMID = 19911970.001).
  • [ISSN] 1537-6591
  • [Journal-full-title] Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • [ISO-abbreviation] Clin. Infect. Dis.
  • [Language] eng
  • [Grant] United States / NCHHSTP CDC HHS / PS / 1H25PS001354-01; United States / NIAID NIH HHS / AI / T32 AI007641-06A2
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  •  go-up   go-down


27. Jones RA, Steeves R, Williams I: How African American men decide whether or not to get prostate cancer screening. Cancer Nurs; 2009 Mar-Apr;32(2):166-72
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] How African American men decide whether or not to get prostate cancer screening.
  • Prostate cancer is the most commonly diagnosed cancer in men in the United States and affects African Americans disproportionately when compared to other ethnic groups.
  • This study interviewed 17 African American men to explore how and when they decided about prostate cancer screening.
  • Most of the men (n = 9) said that they had prostate cancer screening.
  • (1) these men had information on prostate cancer;.
  • (2) family and friends played an important role in the men's decision-making process; and (3) for screening, it was necessary for the men to have a trusting relationship with their healthcare provider.
  • The study's results can help healthcare providers understand some of the important decision-making factors in prostate cancer screening for African American men.

  • Genetic Alliance. consumer health - Prostate cancer.
  • MedlinePlus Health Information. consumer health - African American Health.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ethn Dis. 2000 Winter;10(1):69-75 [10764132.001]
  • [Cites] Oncol Nurs Forum. 2007 Mar;34(2):359-64 [17573300.001]
  • [Cites] Arch Fam Med. 2000 Nov-Dec;9(10):1156-63 [11115223.001]
  • [Cites] Am J Public Health. 2001 May;91(5):805-7 [11344893.001]
  • [Cites] Cancer Nurs. 2001 Jun;24(3):165-71 [11409059.001]
  • [Cites] BMJ. 2001 Nov 3;323(7320):1058-60 [11691768.001]
  • [Cites] Cancer Nurs. 2002 Feb;25(1):28-34 [11838717.001]
  • [Cites] J Clin Oncol. 2002 Apr 1;20(7):1786-92 [11919235.001]
  • [Cites] Oncol Nurs Forum. 2002 Jun;29(5):835-43 [12058158.001]
  • [Cites] Arch Intern Med. 2002 Nov 25;162(21):2458-63 [12437405.001]
  • [Cites] ANS Adv Nurs Sci. 2002 Dec;25(2):22-39 [12484639.001]
  • [Cites] WMJ. 2003;102(5):36-40 [14621929.001]
  • [Cites] Health Expect. 2004 Jun;7(2):126-41 [15117387.001]
  • [Cites] Soc Sci Med. 1987;24(3):187-96 [3824001.001]
  • [Cites] J Gen Intern Med. 1989 Jan-Feb;4(1):23-30 [2644407.001]
  • [Cites] Nursing. 1993 Oct;23(10):44-5 [8414254.001]
  • [Cites] Cancer. 1996 Aug 1;78(3):471-9 [8697393.001]
  • [Cites] Soc Sci Med. 1997 Mar;44(5):681-92 [9032835.001]
  • [Cites] J Natl Med Assoc. 2004 Oct;96(10):1295-302 [15540880.001]
  • [Cites] Health Expect. 2004 Dec;7(4):317-26 [15544684.001]
  • [Cites] Geriatr Nurs. 2004 Nov-Dec;25(6):336-40 [15592249.001]
  • [Cites] Cancer. 2005 May 1;103(9):1819-25 [15795905.001]
  • [Cites] Contemp Clin Trials. 2006 Dec;27(6):580-6 [16839822.001]
  • [Cites] Am J Public Health. 2000 Oct;90(10):1595-600 [11029994.001]
  • (PMID = 19258830.001).
  • [ISSN] 1538-9804
  • [Journal-full-title] Cancer nursing
  • [ISO-abbreviation] Cancer Nurs
  • [Language] ENG
  • [Grant] United States / NINR NIH HHS / NR / NR009009-03; United States / NINR NIH HHS / NR / P20 NR009009; United States / NINR NIH HHS / NR / P20 NR009009-03
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS100176; NLM/ PMC2709174
  •  go-up   go-down


28. Saint-Elie DT, Marshall FF: Impact of laparoscopic inguinal hernia repair mesh on open radical retropubic prostatectomy. Urology; 2010 Nov;76(5):1078-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Of the 949 men who underwent RRP performed by this surgeon, a cohort of 21 men had prior LIHR (a total of 29 IHR: 13 unilateral and 8 bilateral).
  • Of the men, 18 and 3 men presented with T1c and T2a clinical stage, respectively.
  • Preoperatively 18 men, 2 men, and 1 man had a Gleason score of 6, 3+4, and 8, respectively.
  • A total of 4, 4, 11, and 2 men had stage pT2a, pT2b, pT2c, and pT3a, respectively.
  • Fifteen men (71%) had either unilateral (4 men) or bilateral (11) LAD (all pN0), whereas 6 men had no LAD because of severe pelvic scaring.
  • [MeSH-major] Hernia, Inguinal / surgery. Laparoscopy. Prostatectomy. Prostatic Neoplasms / surgery. Surgical Mesh

  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2010 Elsevier Inc. All rights reserved.
  • [CommentIn] Urology. 2011 Apr;77(4):1012-3; author reply 1013 [21477736.001]
  • (PMID = 20363494.001).
  • [ISSN] 1527-9995
  • [Journal-full-title] Urology
  • [ISO-abbreviation] Urology
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


29. Yang YM, Liu TH, Chen YJ, Jiang WJ, Qian JM, Lu X, Gao J, Wu SF, Sang XT, Chen J: Chromosome 1q loss of heterozygosity frequently occurs in sporadic insulinomas and is associated with tumor malignancy. Int J Cancer; 2005 Nov 1;117(2):234-40
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Of 24 tumors without MEN1 LOH, 20 had either SRO-1 or SRO-2 LOH (83%), whereas in 16 tumors with MEN1 LOH, 9 were shown to have LOH at either SRO-1 or SRO-2 (56%) (p = 0.065).
  • This result suggests that LOH at 2 SRO might be MEN1 gene independent and may contribute to the pathogenesis in a subset of insulinomas without MEN1 gene LOH.
  • [MeSH-major] Chromosomes, Human, Pair 1. Insulinoma / genetics. Loss of Heterozygosity. Pancreatic Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15900598.001).
  • [ISSN] 0020-7136
  • [Journal-full-title] International journal of cancer
  • [ISO-abbreviation] Int. J. Cancer
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm; 0 / Insulin
  •  go-up   go-down


30. Fortaleza EA, Tavares RF, Corrêa FM: The medial amygdaloid nucleus modulates cardiovascular responses to acute restraint in rats. Neuroscience; 2009 Mar 17;159(2):717-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The medial amygdaloid nucleus (MeA) modulates several physiological and behavioral processes and among them, the cardiovascular correlates of behavioral responses to stressful stimuli.
  • We presently report effects of MeA pharmacological manipulations on BP and HR responses evoked by acute restraint in rats.
  • Bilateral microinjection of 100 nL of the unspecific synaptic blocker CoCl(2) (1 mM) into the MeA increased HR response to acute restraint, without significant effect on the BP response.
  • This result indicates an inhibitory influence of MeA on restraint-evoked HR changes.
  • These results suggest that local cholinergic neurotransmission and M(1)-receptors mediate the MeA inhibitory influence on restraint-related HR responses.
  • Pretreatment with the M3 receptor antagonist 4-DAMP (4-Diphenylacetoxy-N-methylpiperidine methiodide-2 nmol) did not affect restraint-related cardiovascular responses, reinforcing the idea that M(1)-receptors mediate MeA-related inhibitory influence on restraint-evoked HR increase.

  • Hazardous Substances Data Bank. COBALT, ELEMENTAL .
  • Hazardous Substances Data Bank. COBALTOUS CHLORIDE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19166912.001).
  • [ISSN] 0306-4522
  • [Journal-full-title] Neuroscience
  • [ISO-abbreviation] Neuroscience
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Cholinergic Agents; 3G0H8C9362 / Cobalt; EVS87XF13W / cobaltous chloride
  •  go-up   go-down


31. Triponez F, Cadiot G: Non-functioning tumours of the pancreas in MEN1 patients. J Gastrointestin Liver Dis; 2007 Sep;16(3):295-6
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Non-functioning tumours of the pancreas in MEN1 patients.
  • [MeSH-major] Multiple Endocrine Neoplasia Type 1 / surgery. Pancreatectomy. Pancreatic Neoplasms / surgery

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentOn] J Gastrointestin Liver Dis. 2007 Sep;16(3):257-62 [17925918.001]
  • (PMID = 17925925.001).
  • [ISSN] 1841-8724
  • [Journal-full-title] Journal of gastrointestinal and liver diseases : JGLD
  • [ISO-abbreviation] J Gastrointestin Liver Dis
  • [Language] eng
  • [Publication-type] Comment; Editorial
  • [Publication-country] Romania
  •  go-up   go-down


32. Mitchell JP, Williams N, Martin R, Keshava P, Bynum MM, Figueroa M, Yancy A, DellaRocca R: The Venezuela eye evaluation study. J Natl Med Assoc; 2008 Apr;100(4):435-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There was a relatively low prevalence of glaucoma among men and women.
  • OBJECTIVE: To determine the frequency of ocular disease in rural and urban Venezuela.
  • The main outcome measured was external eye disease: allergic conjunctivitis, dry eyes and pterygia.
  • Open-angle glaucoma was present in 1.2% of women and 1% of men.
  • For participants age > 45, this increased to 1.9% of women and 2.8% of men.
  • There was a relatively low frequency of glaucoma among men and women as compared to Barbados, and a U.S.
  • [MeSH-major] Eye Diseases / diagnosis. Eye Diseases / epidemiology

  • MedlinePlus Health Information. consumer health - Eye Diseases.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18481484.001).
  • [ISSN] 1943-4693
  • [Journal-full-title] Journal of the National Medical Association
  • [ISO-abbreviation] J Natl Med Assoc
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Fernandez A, Karavitaki N, Wass JA: Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin Endocrinol (Oxf); 2010 Mar;72(3):377-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • All cases of PAs were found following an exhaustive computer database search of agreed terms by the staff of each Practice and data on age, gender, presenting manifestations and their duration, imaging features at diagnosis, history of multiple endocrine neoplasia type 1 and family history of PA were collected.
  • RESULTS: A total of 63 patients with PA were identified amongst the study population of 81,149, with a prevalence of 77.6 PA cases/100,000 inhabitants (prolactinomas; PRLoma: 44.4, nonfunctioning PAs: 22.2, acromegaly; ACRO: 8.6, corticotroph adenoma: 1.2 and unknown functional status; UFS: 1.2/100,000 inhabitants).
  • The distribution of each PA subtype was for PRLoma 57%, nonfunctioning PAs 28%, ACRO 11%, corticotroph adenoma 2% and UFS 2%.
  • The median age at diagnosis and the duration of symptoms until diagnosis (in years) were for PRLoma 32.0 and 1.5, nonfunctioning PAs 51.5 and 0.8, ACRO 47 and 4.5 and corticotroph adenoma 57 and 7, respectively.
  • Nonfunctioning PAs dominated in men (57% of all men with PA) and PRLoma in women (76% of all women with PA).
  • [MeSH-major] Adenoma / epidemiology. Pituitary Neoplasms / epidemiology
  • [MeSH-minor] Adolescent. Adult. Aged. Cross-Sectional Studies. Delayed Diagnosis. England / epidemiology. Female. Humans. Male. Middle Aged. Prevalence. Young Adult

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Clin Endocrinol (Oxf). 2010 Mar;72(3):290-1 [19832856.001]
  • (PMID = 19650784.001).
  • [ISSN] 1365-2265
  • [Journal-full-title] Clinical endocrinology
  • [ISO-abbreviation] Clin. Endocrinol. (Oxf)
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


34. Grujić V, Cvejin MM, Nikolić EA, Dragnić N, Jovanović VM, Kvrgić S, Travar S: Association between obesity and socioeconomic factors and lifestyle. Vojnosanit Pregl; 2009 Sep;66(9):705-10
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A cross-sectional study conducted in the Province of Vojvodina in 2006 involved 3 854 participants aged 20 years and over (1 831 men and 2 023 women).
  • The study was a countinuation of the baseline study conducted in 2000 (n = 2 840, 1 255 men and 1 585 women).
  • The prevalence of overweight was higher in men (41.1%) than in women (30.9%) (p < 0.001) while obesity was higher in women (23.10%) as compared to men (20.2%) (p = 0.035).
  • For both sexes, overweight rates were highest at the age 60-69 (men 44.8% and women 39.1%) while obesity rates were peaked to men aged 50-59 (25.1%) and women aged 60-69 years (37.8%).
  • CONCLUSIONS: The population of Vojvodina, with 23.1% obese women and 20.2% obese men is one of severely affected European populations.

  • Genetic Alliance. consumer health - Obesity.
  • MedlinePlus Health Information. consumer health - Obesity.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19877548.001).
  • [ISSN] 0042-8450
  • [Journal-full-title] Vojnosanitetski pregled
  • [ISO-abbreviation] Vojnosanit Pregl
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Serbia
  •  go-up   go-down


35. Ortega Carnicer J: [Acute coronary syndromes with simultaneous elevation of the ST segment in inferior and precordial leads]. Med Intensiva; 2006 May;30(4):143-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS: we studied 10 patients with acute coronary syndrome who had: a) a ST-segment elevation > or = 1 mm in two or more contiguous leads in the inferior and right precordial leads, b) a resolution of the ST-segment elevation and/or the appearance of Q waves or decrease of the R wave amplitude after the disappearance of the angina and c) a coronary angiographic study.
  • RESULTS: There were 9 men and 1 woman, with an average age of 62.6 years.
  • CONCLUSIONS: Most of the patients with acute coronary syndrome associated with simultaneous SST elevation in inferior and right precordial leads had multivessel coronary disease and all patients with only one coronary vessel involved had right ventricular infarction secondary to severe proximal lesion of the right coronary artery.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [CommentIn] Med Intensiva. 2007 Jan-Feb;31(1):53-4; author reply 54 [17306143.001]
  • (PMID = 16750076.001).
  • [ISSN] 0210-5691
  • [Journal-full-title] Medicina intensiva
  • [ISO-abbreviation] Med Intensiva
  • [Language] SPA
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


36. Ochiai A, Troncoso P, Chen ME, Lloreta J, Babaian RJ: The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management. J Urol; 2005 Dec;174(6):2164-8, discussion 2168
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The relationship between tumor volume and the number of positive cores in men undergoing multisite extended biopsy: implication for expectant management.
  • MATERIALS AND METHODS: The study group included 207 men who were treated with radical prostatectomy without neoadjuvant therapy at our cancer center.
  • Bivariate correlation analysis and multiple logistic regression analysis were used to determine the predictors of insignificant cancer.
  • RESULTS: The number of positive cores was significantly related to total tumor volume (r = 0.433, p <0.001).
  • There was a significant difference in the incidence of insignificant cancer among the subgroups (group 1 vs 2 p <0.001, group 1 vs 3 p <0.0001 and group 2 vs 3 p <0.05).
  • Tumor length in a core, Gleason score and prostate volume significantly enhanced the prediction model for insignificant cancer in men with 1 positive core who underwent extended biopsy.
  • [MeSH-major] Biopsy. Prostatic Neoplasms / pathology. Tumor Burden
  • [MeSH-minor] Disease Management. Humans. Logistic Models. Male. Middle Aged. Neoplasm Staging. Predictive Value of Tests. Prostatectomy. Risk Assessment. Risk Factors. Sensitivity and Specificity. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Biopsy.
  • MedlinePlus Health Information. consumer health - Prostate Cancer.
  • COS Scholar Universe. author profiles.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16280756.001).
  • [ISSN] 0022-5347
  • [Journal-full-title] The Journal of urology
  • [ISO-abbreviation] J. Urol.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


37. Zinnamosca L, Petramala L, Cotesta D, Marinelli C, Sciomer S, Cavallaro G, Ciardi A, Massa R, De Toma G, Filetti S, Letizia C: Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report. Endocrine; 2010 Dec;38(3):313-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary aldosteronism due to adrenocortical adenoma with concurrent ileum carcinoid tumor: case report.
  • Primary aldosteronism (PA) with synchronous carcinoid syndrome is extremely rare occurrence.
  • In this article, we describe a case of PA due to adrenocortical adenoma ("aldosteronoma") and concurrent malignant carcinoid tumor of ileum.
  • We report a case of a nonclassical form of multiple endocrine neoplasia type 1 (MEN 1) syndrome.
  • [MeSH-major] Adrenal Cortex Neoplasms / complications. Adrenocortical Adenoma / complications. Carcinoid Tumor / complications. Hyperaldosteronism / complications. Hyperaldosteronism / etiology. Ileal Neoplasms / complications
  • [MeSH-minor] Humans. Liver Neoplasms / diagnostic imaging. Liver Neoplasms / secondary. Male. Middle Aged. Tomography, X-Ray Computed


38. Boikos SA, Stratakis CA: Molecular genetics of the cAMP-dependent protein kinase pathway and of sporadic pituitary tumorigenesis. Hum Mol Genet; 2007 Apr 15;16 Spec No 1:R80-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pituitary tumors are among the most common human neoplasms.
  • The genetic causes of common pituitary tumors remain for the most part unknown; progress has been limited to the elucidation of the molecular etiology of four genetic syndromes predisposing to pituitary neoplasias: McCune-Albright syndrome, multiple endocrine neoplasia type 1, Carney complex and, most recently, familial acromegaly and prolactinomas and other tumors caused by mutations in the GNAS, menin, PRKAR1A, AIP, and p27 (CDKN1B) genes, respectively.
  • Intense molecular studies of sporadic pituitary tumors from patients with negative family histories and no other neoplasms have yielded interesting findings with abnormalities in growth factor expression and cell cycle control dysregulation.
  • To add to the difficulties in understanding pituitary tumorigenesis in man, good murine models of these neoplasms simply do not exist: pituitary tumors are common in rodents, but their histologic origin (mostly from the intermediate lobe), age of presentation (late in murine life) and clinical course make them hardly models of their human counterparts.
  • The present report reviews the clinical and molecular genetics of the cAMP-dependent protein kinase pathway in human pituitary tumors; it also reviews briefly other pathways that have been involved in sporadic pituitary neoplasms.
  • At the end, we attempt a unifying hypothesis for pituitary tumorigenesis, taking into account data that are also discussed elsewhere in this issue.
  • [MeSH-major] Cyclic AMP-Dependent Protein Kinases / genetics. Pituitary Neoplasms / enzymology. Pituitary Neoplasms / genetics
  • [MeSH-minor] Adenoma / enzymology. Adenoma / etiology. Adenoma / genetics. Adenoma / pathology. Animals. Cell Cycle / genetics. Growth Substances / genetics. Humans. Mice. Models, Biological. Molecular Biology. Neoplasm Proteins / genetics. Receptors, Growth Factor / genetics. Securin. Signal Transduction. Syndrome

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17613552.001).
  • [ISSN] 0964-6906
  • [Journal-full-title] Human molecular genetics
  • [ISO-abbreviation] Hum. Mol. Genet.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Growth Substances; 0 / Neoplasm Proteins; 0 / Receptors, Growth Factor; 0 / Securin; EC 2.7.11.11 / Cyclic AMP-Dependent Protein Kinases
  • [Number-of-references] 93
  •  go-up   go-down


39. Sánchez de Cos Escuín J, Miravet Sorribes L, Abal Arca J, Núñez Ares A, Hernández Hernández J, Castañar Jover AM, Muñoz Gutiérrez FJ, García Arangüena L, Alonso MA, Montero Martínez MC, Allende González J, Sánchez Hernández I: [The EpicliCP-2003 study: A multicenter epidemiological and clinical study of lung cancer in Spain]. Arch Bronconeumol; 2006 Sep;42(9):446-52
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Estudio multicéntrico epidemiológico-clínico de cáncer de pulmón en España (estudio EpicliCP-2003).
  • RESULTS: Of a total population of 2,726,601 inhabitants (1 346 483 men and 1 380 118 women), 1064 male and 125 female lung cancer patients were included.
  • The incidence standardized to the world population varied between 42.4/100,000 and 61.8/100,000 in men and between 1.5/100,000 and 8.6/100,000 in women.
  • Overall, 51% were aged over 70 years, and 97.5% of the men and 32% of the women were smokers or ex-smokers.
  • [MeSH-major] Lung Neoplasms / epidemiology

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17040660.001).
  • [ISSN] 0300-2896
  • [Journal-full-title] Archivos de bronconeumología
  • [ISO-abbreviation] Arch. Bronconeumol.
  • [Language] spa
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Multicenter Study
  • [Publication-country] Spain
  •  go-up   go-down


40. Travis WD: Advances in neuroendocrine lung tumors. Ann Oncol; 2010 Oct;21 Suppl 7:vii65-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Multiple endocrine neoplasia type I can be found in TC and AC patients but not those with LCNEC and SCLC.
  • The diagnosis of SCLC, TC and AC can be made by light microscopy without the need for special tests in most cases, but for LCNEC it is required to demonstrate NE differentiation by immunohistochemistry or electron microscopy.

  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20943645.001).
  • [ISSN] 1569-8041
  • [Journal-full-title] Annals of oncology : official journal of the European Society for Medical Oncology
  • [ISO-abbreviation] Ann. Oncol.
  • [Language] ENG
  • [Publication-type] Journal Article; Review
  • [Publication-country] England
  •  go-up   go-down


41. Fajardo-Montañana C, Daly AF, Riesgo-Suárez P, Gómez-Vela J, Tichomirowa MA, Camara-Gómez R, Beckers A: [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature]. Endocrinol Nutr; 2009 Aug-Sep;56(7):369-77
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] Mutaciones de AIP en adenomas hipofisarios familiares y esporádicos: experiencia local y revisión de la literatura.
  • The majority are isolated cases, but their presentation can be familial in the setting of known syndromes such as multiple endocrine neoplasia (MEN)-1 and Carney complex.
  • When 2 or more cases of pituitary adenomas occur in the same family in the absence of the above-mentioned syndromes, a diagnosis of FIPA (familial isolated pituitary adenomas) is made, which accounts for 1-2% of all pituitary adenomas.
  • [MeSH-major] Adenoma / genetics. Intracellular Signaling Peptides and Proteins / genetics. Mutation. Pituitary Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19883897.001).
  • [ISSN] 1575-0922
  • [Journal-full-title] Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición
  • [ISO-abbreviation] Endocrinol Nutr
  • [Language] spa
  • [Publication-type] Case Reports; English Abstract; Journal Article; Review
  • [Publication-country] Spain
  • [Chemical-registry-number] 0 / Intracellular Signaling Peptides and Proteins; 0 / aryl hydrocarbon receptor-interacting protein
  • [Number-of-references] 26
  •  go-up   go-down


42. Nöldge G, Weber MA, Ritzel RA, Werner MJ, Kauczor HU, Grenacher L: [Invasive diagnostic procedures for insulinomas of the pancreas]. Radiologe; 2009 Mar;49(3):224-32
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Insulinomas are the most frequent endocrine tumor of the pancreas and 10% occur as multiple tumors (e.g. multiple endocrine neoplasia type I) or in rare cases as islet cell hyperplasia.
  • [MeSH-major] Angiography. Angiography, Digital Subtraction. Calcium Gluconate. Insulin / blood. Insulinoma / diagnosis. Pancreatic Neoplasms / diagnosis. Phlebography
  • [MeSH-minor] Adult. Blood Specimen Collection. Catheterization, Peripheral. Diagnosis, Differential. Hepatic Artery / diagnostic imaging. Hepatic Veins / diagnostic imaging. Humans. Hyperinsulinism / etiology. Hypoglycemia / etiology. Image Processing, Computer-Assisted. Male. Neoplasm Invasiveness. Sensitivity and Specificity. Tomography, X-Ray Computed

  • MedlinePlus Health Information. consumer health - Diabetes Medicines.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • Hazardous Substances Data Bank. CALCIUM GLUCONATE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Chirurg. 1996 Mar;67(3):268-72 [8681702.001]
  • [Cites] Radiologe. 2003 Apr;43(4):293-300 [12721645.001]
  • [Cites] Surgery. 2000 Dec;128(6):903-9 [11114622.001]
  • [Cites] Chirurg. 1999 Mar;70(3):298-301 [10230544.001]
  • [Cites] Radiologe. 2003 Apr;43(4):301-5 [12721646.001]
  • [Cites] N Engl J Med. 1990 Nov 1;323(18):1246-9 [2170840.001]
  • [Cites] Chirurg. 1997 Apr;68(4):325-33 [9206627.001]
  • [Cites] Radiology. 2000 Jul;216(1):163-71 [10887243.001]
  • [Cites] World J Surg. 1998 Jun;22(6):593-7; discussion 597-8 [9597934.001]
  • [Cites] Abdom Imaging. 1998 May-Jun;23 (3):322-31 [9569307.001]
  • [Cites] Ann Intern Med. 1995 Aug 15;123(4):269-73 [7611592.001]
  • [Cites] N Engl J Med. 1995 Apr 27;332(17):1144-52 [7700289.001]
  • [Cites] Ann Surg. 1990 Nov;212(5):615-20 [2241318.001]
  • [Cites] Gastroenterology. 1997 Feb;112(2):583-90 [9024313.001]
  • [Cites] Pancreas. 2002 Jan;24(1):96-102 [11741188.001]
  • [Cites] Radiology. 1992 Jan;182(1):235-41 [1727289.001]
  • [Cites] Internist (Berl). 2002 Feb;43(2):259-62 [11963761.001]
  • [Cites] Surgery. 1991 Dec;110(6):989-96; discussion 996-7 [1745987.001]
  • [Cites] Wien Klin Wochenschr. 2004 Jun 30;116(11-12):373-8 [15291289.001]
  • [Cites] Chirurg. 1997 Feb;68(2):116-21 [9156976.001]
  • [Cites] World J Surg. 1993 Jul-Aug;17 (4):427-32 [8362525.001]
  • [Cites] Radiology. 1998 Mar;206(3):703-9 [9494488.001]
  • [Cites] Br J Surg. 2000 Apr;87(4):385-7 [10759726.001]
  • [Cites] Metabolism. 2003 Oct;52(10):1320-9 [14564685.001]
  • [Cites] Radiology. 1991 Jan;178(1):237-41 [1984311.001]
  • [Cites] Ann Surg. 1987 Mar;205(3):230-9 [3548610.001]
  • [Cites] Surgery. 1997 Dec;122(6):1189-93; discussion 1193-4 [9426437.001]
  • [Cites] Chirurg. 2000 Oct;71(10):1236-42 [11077585.001]
  • [Cites] Eur J Clin Invest. 1998 Dec;28(12):1038-49 [9893017.001]
  • [Cites] Ann Surg Oncol. 2007 Jul;14(7):2121-7 [17431724.001]
  • [Cites] Ital J Gastroenterol Hepatol. 1999 Oct;31 Suppl 2:S163-6 [10604123.001]
  • [Cites] Prog Biophys Mol Biol. 1989;54(2):87-143 [2484976.001]
  • [Cites] J Am Coll Surg. 2002 Jun;194(6):761-4 [12081066.001]
  • [Cites] AJR Am J Roentgenol. 1990 Nov;155(5):995-6 [2120971.001]
  • [Cites] Br J Surg. 1994 Feb;81(2):164-6 [8156325.001]
  • [Cites] Rev Diabet Stud. 2004 Spring;1(1):42-6 [17491664.001]
  • [Cites] Best Pract Res Clin Endocrinol Metab. 2005 Jun;19(2):229-39 [15763697.001]
  • [Cites] Radiology. 1993 Mar;186(3):799-802 [8381551.001]
  • (PMID = 19198794.001).
  • [ISSN] 1432-2102
  • [Journal-full-title] Der Radiologe
  • [ISO-abbreviation] Radiologe
  • [Language] ger
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Insulin; SQE6VB453K / Calcium Gluconate
  •  go-up   go-down


43. Falchetti A, Cilotti A, Vaggelli L, Masi L, Amedei A, Cioppi F, Tonelli F, Brandi ML: A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet. Nat Clin Pract Endocrinol Metab; 2008 Jun;4(6):351-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.
  • BACKGROUND: A 30-year-old woman with suspected multiple endocrine neoplasia type 1 (MEN1) was referred to our center in 2001 with primary hyperparathyroidism caused by a multiglandular parathyroid adenoma.
  • MEN1 was confirmed by analysis of the MEN1 gene, which revealed a 1555insG frameshift mutation.
  • DIAGNOSIS: Local recurrence of a parathyroid adenoma associated with MEN1.
  • Cinacalcet could represent an important pharmacological intervention in MEN1-associated primary hyperparathyroidism before surgery and in postsurgical recurrences.
  • [MeSH-major] Hyperparathyroidism, Primary / drug therapy. Multiple Endocrine Neoplasia Type 1 / complications. Naphthalenes / therapeutic use

  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. CALCIUM, ELEMENTAL .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [ErratumIn] Nat Clin Pract Endocrinol Metab. 2008 Jul;4(7):420. Vagelli, Luca [corrected to Vaggelli, Luca]
  • (PMID = 18414463.001).
  • [ISSN] 1745-8374
  • [Journal-full-title] Nature clinical practice. Endocrinology & metabolism
  • [ISO-abbreviation] Nat Clin Pract Endocrinol Metab
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Naphthalenes; 0 / Parathyroid Hormone; 1K860WSG25 / Cinacalcet Hydrochloride; SY7Q814VUP / Calcium
  •  go-up   go-down


44. Jaski BE, Miller DA, Hoagland PM, Gordon JB, Chillcott SR, Stahovich MJ, Adamson RM, Baradarian S, Dembitsky WP: Assessment of recurrent heart failure associated with left ventricular assist device dysfunction. J Heart Lung Transplant; 2005 Dec;24(12):2060-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Compared with the diagnosis of native heart dysfunction, there is less experience with the assessment of recurrent heart failure after LVAD placement.
  • METHODS: Ten patients (9 men, 1 woman; age, 58 +/- 11 years) were studied after LVAD placement.
  • Cardiac catheterization can confirm the diagnosis before surgical intervention.

  • MedlinePlus Health Information. consumer health - Heart Failure.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16364850.001).
  • [ISSN] 1557-3117
  • [Journal-full-title] The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
  • [ISO-abbreviation] J. Heart Lung Transplant.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


45. van Roon EN, van den Bemt PM, Jansen TL, Houtman NM, van de Laar MA, Brouwers JR: An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists. Clin Ther; 2009 Aug;31(8):1737-46
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] An evidence-based assessment of the clinical significance of drug-drug interactions between disease-modifying antirheumatic drugs and non-antirheumatic drugs according to rheumatologists and pharmacists.
  • OBJECTIVE: This study evaluates the interdisciplinary agreement between rheumatologists and clinical (hospital) pharmacists in assessing the clinical relevance of DDIs with disease-modifying antirheumatic drugs (DMARDs) and non-DMARD medications.
  • The following search terms were used for the key word, title, and abstract sections of the publications: interaction(s), DMARD, disease-modifying antirheumatic drug(s), antirheumatic, rheumatology, rheumatoid arthritis, and the names of the individual DMARDs of interest (abatacept, adalimumab, anakinra, auranofin, aurothioglucose, aurothiomalate, d-penicillamine, etanercept, gold, [hydroxy]-chloroquine, interleukin-1 receptor antagonist, IL1-RA, infliximab, leflunomide, methotrexate, rituximab, and sulfasalazine/sulphasalazine).
  • Both groups consisted of 3 members (2 men and 1 woman), aged 40 to 60 years, who had >5 years of clinical experience and were currently involved in clinical practice in large, nonacademic teaching hospitals in the Netherlands.

  • MedlinePlus Health Information. consumer health - Rheumatoid Arthritis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19808132.001).
  • [ISSN] 1879-114X
  • [Journal-full-title] Clinical therapeutics
  • [ISO-abbreviation] Clin Ther
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antirheumatic Agents
  • [Number-of-references] 72
  •  go-up   go-down


46. Aksglaede L, Jørgensen N, Skakkebaek NE, Juul A: Low semen volume in 47 adolescents and adults with 47,XXY Klinefelter or 46,XX male syndrome. Int J Androl; 2009 Aug;32(4):376-84
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Low semen volume in 47 adolescents and adults with 47,XXY Klinefelter or 46,XX male syndrome.
  • Klinefelter syndrome is characterized by progressive testicular failure causing androgen deficiency and azoospermia in most patients.
  • Semen quality was compared with 2136 (control group I) men from the general population aged 18.9 (17.9-28.6) years and with 349 fertile men (control group II) aged 30.9 (22.0-43.8) years.
  • [MeSH-major] Azoospermia / pathology. Chromosomes, Human, X. Chromosomes, Human, Y. Klinefelter Syndrome / pathology. Semen Analysis


47. Wang Q, Pang YP: Normal-mode-analysis-monitored energy minimization procedure for generating small-molecule bound conformations. PLoS One; 2007 Oct 10;2(10):e1025
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Here we report a normal-mode-analysis-monitored energy minimization (NEM) procedure that generates local minimum conformations as potential bound conformations.
  • Of 22 selected guest-host complex crystal structures with guest structures possessing up to four rotatable bonds, all complexes were reproduced, with guest mass-weighted root mean square deviations of <1.0 A, through docking with the NEM-generated guest local minimum conformations.
  • These results suggest that (1) the NEM procedure can generate small-molecule bound conformations, and (2) guests adopt low-strain-energy conformations for complexation, thus supporting the virtual screening methods that use local minimum conformations.

  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Comput Aided Mol Des. 1995 Dec;9(6):491-9 [8789191.001]
  • [Cites] Protein Sci. 1998 Mar;7(3):649-66 [9541397.001]
  • [Cites] J Comput Aided Mol Des. 1998 Jul;12(4):383-96 [9777496.001]
  • [Cites] Proteins. 2004 Dec 1;57(4):747-57 [15690493.001]
  • [Cites] Clin Pharmacol Ther. 2007 Jan;81(1):30-4 [17185996.001]
  • [Cites] PLoS One. 2007;2(6):e531 [17565384.001]
  • [Cites] Trends Pharmacol Sci. 1996 May;17(5):189; discussion 190-1 [8669125.001]
  • [Cites] Proteins. 2002 Aug 15;48(3):487-96 [12112673.001]
  • [Cites] J Mol Biol. 2002 Nov 8;323(5):927-37 [12417204.001]
  • [Cites] Nature. 2002 Nov 7;420(6911):102-6 [12422224.001]
  • [Cites] Biochemistry. 2003 Aug 5;42(30):8945-56 [12885227.001]
  • [Cites] Fed Proc. 1981 Nov;40(13):2723-8 [7297703.001]
  • [Cites] PLoS One. 2007;2(9):e820 [17786192.001]
  • (PMID = 17925873.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] ENG
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI054574; United States / NIGMS NIH HHS / GM / R01 GM061300; United States / NIAID NIH HHS / AI / 5R01AI054574-03; United States / NIGMS NIH HHS / GM / 5R01GM061300-06
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Proteins
  • [Other-IDs] NLM/ PMC1995756
  •  go-up   go-down


48. Hyer SL, Newbold K, Harmer C: Familial medullary thyroid cancer: clinical aspects and prognosis. Eur J Surg Oncol; 2005 May;31(4):415-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Fifty five patients (25 males, 30 females) were identified with at least two first-degree relatives affected by medullary thyroid cancer; 26 were classified as MEN 2A, 1 as MEN 2B and 28 as FMTC.
  • Median age at diagnosis was 35 years (MEN 2A), 25 (MEN 2B) and 47.5 (FMTC).
  • Cause specific survival was 89% at 10 years and 77% at 20 years for MEN patients, 51% and 32% for those with sporadic MTC, and 46% and 26% for those with FMTC.
  • In multivariate analysis, factors predicting survival were presence of metastases, nodal status and age at diagnosis.
  • CONCLUSIONS: Improved survival rates associated with familial types of MTC can be accounted for by the earlier stage at which disease is detected and the younger age at presentation.
  • [MeSH-major] Carcinoma, Medullary / genetics. Thyroid Neoplasms / genetics


49. Nettleship JE, Pugh PJ, Channer KS, Jones T, Jones RD: Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease. Horm Metab Res; 2007 May;39(5):366-71
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease.
  • OBJECTIVES: To examine the relationship between serum levels of inflammatory cytokines and testosterone in men with stable coronary artery disease (CAD).
  • Evidence supports a beneficial effect of testosterone upon objective measures of myocardial ischaemia in men with CAD, and in animal models of atherosclerosis.
  • METHODS: Serum was collected from 69 men (59+/-1 years) having >75% occlusion of 1, 2, or 3 coronary arteries.
  • Levels of total testosterone (TT), bioavailable testosterone (BT), tumour necrosis factor-alpha (TNFalpha), interleukin (IL)-1-beta (IL-1beta), IL-6 and IL-10 were measured and analysis made between men with 1, 2, or 3 vessel CAD, and between men with hypogonadal, borderline hypogonadal and eugonadal serum levels of testosterone.
  • A significant stepwise increase in levels of IL-1beta was also observed in eugonadal, borderline hypogonadal, and hypogonadal men: 0.19+/-0.05, 0.29+/-0.05, and 0.46+/-0.13 pg/ml (p=0.047).
  • CONCLUSION: Consequently this data implicates IL-1beta and IL-10 in the pathogenesis of CAD and suggests that testosterone may regulate IL-1beta activity in men with CAD.
  • [MeSH-major] Coronary Artery Disease / blood. Interleukin-1beta / blood. Testosterone / blood

  • MedlinePlus Health Information. consumer health - Coronary Artery Disease.
  • Hazardous Substances Data Bank. TESTOSTERONE .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17533579.001).
  • [ISSN] 0018-5043
  • [Journal-full-title] Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et métabolisme
  • [ISO-abbreviation] Horm. Metab. Res.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Interleukin-1beta; 0 / Interleukin-6; 0 / Tumor Necrosis Factor-alpha; 130068-27-8 / Interleukin-10; 3XMK78S47O / Testosterone
  •  go-up   go-down


50. Berna MJ, Annibale B, Marignani M, Luong TV, Corleto V, Pace A, Ito T, Liewehr D, Venzon DJ, Delle Fave G, Bordi C, Jensen RT: A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors. J Clin Endocrinol Metab; 2008 May;93(5):1582-91
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] A prospective study of gastric carcinoids and enterochromaffin-like cell changes in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: identification of risk factors.
  • CONTEXT: Multiple endocrine neoplasia type 1 (MEN1) patients frequently develop Zollinger-Ellison syndrome (ZES).
  • ECL-cell changes have been extensively studied in sporadic ZES patients and can be precursor lesions of gastric carcinoids, but little is known about factors influencing their severity or development of carcinoids in MEN1/ZES patients.
  • OBJECTIVES: Our objective was to prospectively analyze ECL-cell changes and gastric carcinoids (ECL-cell tumors) in a large series of MEN1/ZES patients to detect risk factors and deduct clinical guidelines.
  • SETTING AND PATIENTS: Fifty-seven consecutive MEN1/ZES patients participated in this prospective study at two tertiary-care research centers.
  • INTERVENTIONS AND OUTCOME MEASURES: Assessment of MEN1, gastric hypersecretion, and gastroscopy with multiple biopsies was done according to a fixed protocol and tumor status.
  • ECL-cell changes and alpha-human chorionic gonadotropin staining were assessed in each biopsy and correlated with clinical, laboratory, and MEN1 features.
  • Patients with high fasting serum gastrin levels, long disease duration, or a strong alpha-human chorionic gonadotropin staining in a biopsy are at higher risk for an advanced ECL-cell lesion and/or gastric carcinoid.
  • CONCLUSIONS: Gastric carcinoids and/or advanced ECL-cell changes are frequent in MEN1/ZES patients, and therefore, regular surveillance gastroscopy with multiple routine biopsies and biopsies of all mucosal lesions are essential.
  • Clinical/laboratory data and biopsy results can be used to identify a subgroup of MEN1/ZES patients with a significantly increased risk for developing gastric carcinoids, allowing development of better surveillance strategies.


51. Koh CS, Ku JL, Park SY, Kim KH, Choi JS, Kim IJ, Park JH, Oh SK, Chung JK, Lee JH, Kim WH, Kim CW, Cho BY, Park JG: Establishment and characterization of cell lines from three human thyroid carcinomas: responses to all-trans-retinoic acid and mutations in the BRAF gene. Mol Cell Endocrinol; 2007 Jan 29;264(1-2):118-27
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mutations of the p53 gene were found in two lines (SNU-80 and SNU-373), but no mutations in the RET or MEN1 genes were observed.
  • [MeSH-major] Antineoplastic Agents / pharmacology. Cell Line, Tumor / metabolism. Mutation. Proto-Oncogene Proteins B-raf / genetics. Thyroid Neoplasms / metabolism. Tretinoin / pharmacology


52. Lakhani VT, You YN, Wells SA: The multiple endocrine neoplasia syndromes. Annu Rev Med; 2007;58:253-65
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The multiple endocrine neoplasia syndromes.
  • Multiple endocrine neoplasia (MEN) type 1 and type 2 exhibit an autosomal dominant pattern of inheritance.
  • The large majority of patients with MEN1 have mutations in the menin gene.
  • Specific codon mutations within RET correlate with disease phenotype and severity.
  • [MeSH-major] Multiple Endocrine Neoplasia


53. Milne TA, Hughes CM, Lloyd R, Yang Z, Rozenblatt-Rosen O, Dou Y, Schnepp RW, Krankel C, Livolsi VA, Gibbs D, Hua X, Roeder RG, Meyerson M, Hess JL: Menin and MLL cooperatively regulate expression of cyclin-dependent kinase inhibitors. Proc Natl Acad Sci U S A; 2005 Jan 18;102(3):749-54
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Mutations in the MEN1 gene are associated with the multiple endocrine neoplasia syndrome type 1 (MEN1), which is characterized by parathyroid hyperplasia and tumors of the pituitary and pancreatic islets.
  • The mechanism by which MEN1 acts as a tumor suppressor is unclear.
  • We have recently shown that menin, the MEN1 protein product, interacts with mixed lineage leukemia (MLL) family proteins in a histone methyltransferase complex including Ash2, Rbbp5, and WDR5.

  • COS Scholar Universe. author profiles.
  • Gene Ontology. gene/protein/disease-specific - Gene Ontology annotations from this paper .
  • KOMP Repository. gene/protein/disease-specific - KOMP Repository (subscription/membership/fee required).
  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Trends Mol Med. 2004 Oct;10(10):500-7 [15464450.001]
  • [Cites] Cancer Res. 2004 Sep 15;64(18):6791-6 [15374998.001]
  • [Cites] Cell. 1994 Jul 15;78(1):59-66 [8033212.001]
  • [Cites] Genes Dev. 1994 Dec 15;8(24):2939-52 [8001816.001]
  • [Cites] Genes Dev. 1995 May 15;9(10):1149-63 [7758941.001]
  • [Cites] Am J Pathol. 1997 Feb;150(2):401-7 [9033255.001]
  • [Cites] Science. 1997 Apr 18;276(5311):404-7 [9103196.001]
  • [Cites] Hum Mol Genet. 1997 Jul;6(7):1177-83 [9215690.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4152-7 [9539705.001]
  • [Cites] Genes Dev. 1998 Sep 15;12(18):2899-911 [9744866.001]
  • [Cites] Nature. 1998 Nov 12;396(6707):177-80 [9823898.001]
  • [Cites] Int J Cancer. 1999 Jan 18;80(2):205-9 [9935201.001]
  • [Cites] Oncogene. 1999 Sep 2;18(35):4948-57 [10490829.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Oct;84(10):3823-30 [10523037.001]
  • [Cites] Cancer Res. 2004 Oct 1;64(19):7039-44 [15466197.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Nov 9;96(23):13462-7 [10557343.001]
  • [Cites] Br J Haematol. 2000 Sep;110(3):663-73 [10997979.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1118-23 [11158604.001]
  • [Cites] Mol Cell Biol. 2001 Apr;21(7):2249-58 [11259575.001]
  • [Cites] Leuk Lymphoma. 2001 Jan;40(3-4):259-66 [11426547.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):12902-7 [11687631.001]
  • [Cites] Science. 2001 Nov 9;294(5545):1331-4 [11701926.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Jan 8;99(1):90-4 [11752412.001]
  • [Cites] Exp Hematol. 2002 Jan;30(1):49-57 [11823037.001]
  • [Cites] Genesis. 2002 Feb;32(2):150-1 [11857805.001]
  • [Cites] Cancer Lett. 2003 Jan 10;189(1):1-10 [12445671.001]
  • [Cites] Mol Cell. 2002 Nov;10(5):1107-17 [12453418.001]
  • [Cites] Mol Cell. 2002 Nov;10(5):1119-28 [12453419.001]
  • [Cites] Mol Cell Biol. 2003 Feb;23(4):1269-77 [12556487.001]
  • [Cites] Cancer Res. 2003 Jul 15;63(14):4204-10 [12874027.001]
  • [Cites] Mol Cell Biol. 2003 Sep;23(17):6075-85 [12917331.001]
  • [Cites] Cancer Res. 2003 Aug 15;63(16):4836-41 [12941803.001]
  • [Cites] Cancer Res. 2003 Sep 1;63(17):5420-7 [14500377.001]
  • [Cites] J Clin Invest. 2004 Jan;113(2):175-9 [14722607.001]
  • [Cites] Cell. 2004 Jan 23;116(2):235-46 [14744434.001]
  • [Cites] Nat Rev Cancer. 2004 Feb;4(2):133-42 [14964309.001]
  • [Cites] Mol Cell. 2004 Feb 27;13(4):587-97 [14992727.001]
  • [Cites] Clin Endocrinol (Oxf). 2004 Mar;60(3):389-93 [15009006.001]
  • [Cites] Gene. 2004 Apr 28;331:53-63 [15094191.001]
  • [Cites] Ann N Y Acad Sci. 2004 Apr;1014:189-98 [15153434.001]
  • [Cites] J Biol Chem. 2004 Jun 4;279(23):24477-84 [15054094.001]
  • [Cites] Mol Cell Biol. 2004 Jul;24(13):5639-49 [15199122.001]
  • [Cites] Nucleic Acids Res. 1983 Mar 11;11(5):1475-89 [6828386.001]
  • (PMID = 15640349.001).
  • [ISSN] 0027-8424
  • [Journal-full-title] Proceedings of the National Academy of Sciences of the United States of America
  • [ISO-abbreviation] Proc. Natl. Acad. Sci. U.S.A.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / CDKN1B protein, human; 0 / CDKN2C protein, human; 0 / Carrier Proteins; 0 / Cell Cycle Proteins; 0 / Cyclin-Dependent Kinase Inhibitor p18; 0 / DNA-Binding Proteins; 0 / Intracellular Signaling Peptides and Proteins; 0 / MEN1 protein, human; 0 / MLL protein, human; 0 / Proto-Oncogene Proteins; 0 / Transcription Factors; 0 / Tumor Suppressor Proteins; 147604-94-2 / Cyclin-Dependent Kinase Inhibitor p27; 149025-06-9 / Myeloid-Lymphoid Leukemia Protein; EC 2.1.1.43 / Histone-Lysine N-Methyltransferase; EC 2.7.11.22 / Cyclin-Dependent Kinases
  • [Other-IDs] NLM/ PMC545577
  •  go-up   go-down


54. Matsuda KM, Nóbrega R, Quezado M, Schrump DS, Filie AC: Melanocytic bronchopulmonary carcinoid tumor in a patient with multiple endocrine neoplasia syndrome type 1: a case report with emphasis on intraoperative cytological findings. Diagn Cytopathol; 2010 Sep;38(9):669-74
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Melanocytic bronchopulmonary carcinoid tumor in a patient with multiple endocrine neoplasia syndrome type 1: a case report with emphasis on intraoperative cytological findings.
  • We present the cytological features along with histologic and imaging findings of a melanocytic bronchopulmonary carcinoid tumor in a patient with multiple endocrine neoplasia syndrome type 1 (MEN-1).
  • The findings were consistent with melanocytic bronchopulmonary carcinoid tumor, which is relatively uncommon in MEN-1.
  • [MeSH-major] Carcinoid Tumor / complications. Carcinoid Tumor / pathology. Lung Neoplasms / complications. Lung Neoplasms / pathology. Melanocytes / pathology. Multiple Endocrine Neoplasia Type 1 / complications. Multiple Endocrine Neoplasia Type 1 / pathology


55. Kronborg J, Solbu M, Njølstad I, Toft I, Eriksen BO, Jenssen T: Predictors of change in estimated GFR: a population-based 7-year follow-up from the Tromso study. Nephrol Dial Transplant; 2008 Sep;23(9):2818-26
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Chronic kidney disease is associated with increased cardiovascular mortality, and even mild impairment of renal function is a cardiovascular risk factor.
  • Several studies have investigated the risk factors for the development of end-stage renal disease, but little is known about predictors of change in renal function in the general population.
  • METHODS: The present study included 2249 men and 2192 women without signs of kidney disease at baseline who were followed for 7 years from 1994 to 1995 in the Tromsø Study.
  • Estimated glomerular filtration rate (eGFR) was calculated from the Modification of Diet in Renal Disease study equation.
  • Gender-specific multiple linear regression analyses were used to assess predictors of change in eGFR (DeltaGFR).
  • RESULTS: Change in eGFR, measured in ml/min/1.73 m(2)/year, was associated with systolic blood pressure (SBP) [beta-value for a 10-mmHg increase in SBP, men = -0.14, 95% confidence interval (CI) = -0.18 to -0.09; women = -0.07, 95% CI = -0.11 to -0.03] and fibrinogen [beta-value for 1 SD increase in fibrinogen, men (1 SD: 0.85 g/L) = -0.12, 95% CI -0.20 to -0.03; women (1 SD: 0.80) = -0.11, 95% CI -0.20 to -0.02].
  • High alcohol consumption in men and high physical activity in women predicted an increase in eGFR.
  • Higher albumin/creatinine ratio was associated with a decline in eGFR in men only.
  • CONCLUSIONS: Some risk factors for change in GFR seem to be gender specific but both high SBP and high levels of fibrinogen contribute to a more rapid decline in GFR for both men and women.

  • MedlinePlus Health Information. consumer health - Chronic Kidney Disease.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18400822.001).
  • [ISSN] 1460-2385
  • [Journal-full-title] Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association
  • [ISO-abbreviation] Nephrol. Dial. Transplant.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] England
  • [Chemical-registry-number] 9001-32-5 / Fibrinogen; AYI8EX34EU / Creatinine
  •  go-up   go-down


56. Gladman DD, Inman RD, Cook RJ, Maksymowych WP, Braun J, Davis JC, Landewé RB, Mease P, Brandt J, Vargas RB, Chandran V, Helliwell P, Kavanaugh A, O'Shea FD, Khan MA, Pipitone N, Rahman P, Reveille JD, Stone MA, Taylor W, Veale DJ, van der Heijde D: International spondyloarthritis interobserver reliability exercise--the INSPIRE study: II. Assessment of peripheral joints, enthesitis, and dactylitis. J Rheumatol; 2007 Aug;34(8):1740-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: To determine whether the assessments of peripheral joints and enthesitis were reproducible for both AS and PsA with axial disease, and whether dactylitis assessment is reproducible in patients with PsA.
  • METHODS: A group of 20 rheumatologists from 11 countries with expertise in spondyloarthritis (SpA) met for a combined physical examination exercise to assess 10 patients with PsA with axial involvement (9 men, 1 woman, mean age 52 yrs, disease duration 17 yrs) and 9 patients with AS (7 men, 2 women, mean age 38 yrs, disease duration 16 yrs).


57. Tonelli F, Fratini G, Nesi G, Tommasi MS, Batignani G, Falchetti A, Brandi ML: Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias. Ann Surg; 2006 Jul;244(1):61-70
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
  • OBJECTIVE: The aim of this study was to evaluate the results of pancreatic resection in pancreatic endocrine neoplasias (PENs) in patients affected by multiple endocrine neoplasia type 1 (MEN1) syndrome.
  • BACKGROUND: Since these tumors often show an indolent course, the role of diagnostic procedures and type of surgical approach are controversial.
  • METHODS: Sixteen MEN1 patients were referred to our Surgical Unit (1992-2003) and were operated on for the indications of hypergastrinism, hypoglycemia, and/or pancreatic endocrine neoplasias larger than 1 cm.
  • Zollinger-Ellison syndrome (ZES) was present in 13 patients, 2 of whom experienced a recurrence after previous surgery.
  • At follow-up, 10 of 13 hypergastrinemic patients (77%) are currently eugastrinemic with negative secretin provocative test, while 3 are showing a recurrence of the disease.
  • CONCLUSIONS: MEN1 tumors should be considered surgically curable diseases.
  • Our experience suggests that PD is superior to less radical surgical approaches in providing cure with limited morbidity in MEN1 gastrinomas and pancreatic neoplasias.
  • [MeSH-major] Gastrinoma / surgery. Multiple Endocrine Neoplasia Type 1 / surgery. Pancreatectomy. Pancreatic Neoplasms / surgery
  • [MeSH-minor] Adult. Female. Humans. Male. Middle Aged. Pancreaticoduodenectomy. Postoperative Complications. Zollinger-Ellison Syndrome / diagnosis. Zollinger-Ellison Syndrome / surgery

  • Genetic Alliance. consumer health - Multiple Endocrine Neoplasia.
  • Genetic Alliance. consumer health - Multiple endocrine neoplasia type 1.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Clin Endocrinol Metab. 2001 May;86(5):2236-42 [11344233.001]
  • [Cites] World J Gastroenterol. 2005 Apr 28;11(16):2456-61 [15832417.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Nov;86(11):5282-93 [11701693.001]
  • [Cites] J Clin Endocrinol Metab. 2001 Dec;86(12):5658-71 [11739416.001]
  • [Cites] Langenbecks Arch Surg. 2002 Mar;386(8):558-69 [11914931.001]
  • [Cites] Arch Surg. 2002 Jun;137(6):641-7 [12049533.001]
  • [Cites] Arch Surg. 2002 Sep;137(9):1044-7; discussion 1048 [12215157.001]
  • [Cites] Gastroenterology. 1979 Sep;77(3):444-50 [456840.001]
  • [Cites] Cancer. 1986 May 1;57(9):1824-32 [2420439.001]
  • [Cites] Surgery. 1989 Dec;106(6):1081-5; discussion 1085-6 [2573955.001]
  • [Cites] Ann Surg. 1989 Dec;210(6):710-8 [2589884.001]
  • [Cites] Arch Intern Med. 1989 Dec;149(12):2717-22 [2574567.001]
  • [Cites] N Engl J Med. 1990 Mar 15;322(11):723-7 [1968616.001]
  • [Cites] Surg Gynecol Obstet. 1990 Jun;170(6):476-84 [2188384.001]
  • [Cites] World J Surg. 1991 Jan-Feb;15(1):151-9 [1671617.001]
  • [Cites] J Clin Endocrinol Metab. 1991 Aug;73(2):281-7 [1677362.001]
  • [Cites] Surgery. 1991 Dec;110(6):998-1004; discussion 1004-5 [1684067.001]
  • [Cites] Surgery. 1992 Dec;112(6):1016-22; discussion 1022-3 [1360709.001]
  • [Cites] Henry Ford Hosp Med J. 1992;40(3-4):195-8 [1362404.001]
  • [Cites] World J Surg. 1993 Jul-Aug;17(4):433-8 [8362526.001]
  • [Cites] World J Surg. 1993 Jul-Aug;17(4):489-97 [8103251.001]
  • [Cites] Am J Surg. 1995 Jan;169(1):179-85 [7817989.001]
  • [Cites] World J Surg. 1994 Jul-Aug;18(4):488-93; discussion 493-4 [7725733.001]
  • [Cites] Surgery. 1995 Jun;117(6):629-35 [7778027.001]
  • [Cites] Eur J Endocrinol. 2000 Feb;142(2):131-7 [10664520.001]
  • [Cites] Ann Surg. 2000 Jun;231(6):909-18 [10816635.001]
  • [Cites] Ann Surg. 2000 Sep;232(3):419-29 [10973392.001]
  • [Cites] Surgery. 1995 Dec;118(6):973-9; discussion 979-80 [7491542.001]
  • [Cites] World J Surg. 1996 Feb;20(2):168-72 [8661813.001]
  • [Cites] World J Surg. 1996 Sep;20(7):872-6; discussion 877 [8678965.001]
  • [Cites] World J Surg. 2000 Nov;24(11):1425-30 [11038217.001]
  • [Cites] Surgery. 2000 Dec;128(6):958-66 [11114630.001]
  • [Cites] Surgery. 2001 Jan;129(1):91-5 [11150038.001]
  • [Cites] J Clin Endocrinol Metab. 1997 Feb;82(2):357-64 [9024218.001]
  • [Cites] Am J Surg. 1997 Apr;173(4):257-63 [9136776.001]
  • [Cites] World J Surg. 1998 Jul;22(7):643-9; discussion 649-50 [9606276.001]
  • [Cites] J Intern Med. 1998 Jun;243(6):495-500 [9681848.001]
  • [Cites] J Intern Med. 1998 Jun;243(6):589-94 [9681863.001]
  • [Cites] Surgery. 1998 Dec;124(6):1134-43; discussion 1143-4 [9854595.001]
  • [Cites] Br J Surg. 1999 May;86(5):603-7 [10361177.001]
  • [Cites] Ann Oncol. 1999;10 Suppl 4:170-6 [10436815.001]
  • [Cites] N Engl J Med. 1999 Aug 26;341(9):635-44 [10460814.001]
  • [Cites] Ann Surg. 2001 Oct;234(4):495-505; discussion 505-6 [11573043.001]
  • (PMID = 16794390.001).
  • [ISSN] 0003-4932
  • [Journal-full-title] Annals of surgery
  • [ISO-abbreviation] Ann. Surg.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC1570585
  •  go-up   go-down


58. Pachocka LM, Bułhak-Jachymczyk B, Kłosiewicz-Latoszek L, Stolarska I, Grzybek A, Targosz U: [Antioxidant vitamins status in patients with combined hyperlipidemia]. Ann Acad Med Stetin; 2005;51 Suppl 1:119-23
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The energy intake in men was 2269.6 kcal, vitamin A consumption was 888.3 microg, vitamin E 8.7 mg and vitamin C 68.6 mg.
  • Only in 1 men deficient concentration of vitamin C was stated.
  • Deficient concentration of vitamin A was not found but the desirable concentration was stated only in 5 men.
  • The desirable vitamin E level was found only in men, not in women.

  • MedlinePlus Health Information. consumer health - Antioxidants.
  • MedlinePlus Health Information. consumer health - Vitamin A.
  • MedlinePlus Health Information. consumer health - Vitamin C.
  • MedlinePlus Health Information. consumer health - Vitamin E.
  • Hazardous Substances Data Bank. Sodium ascorbate .
  • Hazardous Substances Data Bank. L-Ascorbic Acid .
  • Hazardous Substances Data Bank. VITAMIN A .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16602438.001).
  • [ISSN] 1427-440X
  • [Journal-full-title] Annales Academiae Medicae Stetinensis
  • [ISO-abbreviation] Ann Acad Med Stetin
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Poland
  • [Chemical-registry-number] 0 / Antioxidants; 0 / Lipids; 0 / Lipoproteins; 11103-57-4 / Vitamin A; 1406-18-4 / Vitamin E; PQ6CK8PD0R / Ascorbic Acid
  •  go-up   go-down


59. Rigabert J, De Clermont H: [Diagnostic procedures and more particularly, place of scintigraphy in neuroendocrine tumors, example of vipoma in MEN 1]. Ann Endocrinol (Paris); 2007 Jun;68(2-3):199-203
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic procedures and more particularly, place of scintigraphy in neuroendocrine tumors, example of vipoma in MEN 1].
  • [Transliterated title] Outils diagnostiques et plus particulièrement, place de la scintigraphie dans les tumeurs neuroendocrines: l'exemple d'un vipome dans une NEM de type 1.
  • Functioning endocrine pancreatic tumors in multiple endocrine neoplasia type 1 (MEN1) are rare.
  • This case is interesting in many ways: this is an exceptional illustration of MEN 1 with vipoma associated with calcitonin secretion and it is also a good example of the benefits and limitations of each diagnostic procedure in the heterogeneous group of neuroendocrine tumors.
  • [MeSH-major] Multiple Endocrine Neoplasia Type 1 / diagnosis. Neuroendocrine Tumors / diagnosis. Vipoma / diagnosis

  • Genetic Alliance. consumer health - VIPoma.
  • Hazardous Substances Data Bank. Calcitonin .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17292846.001).
  • [ISSN] 0003-4266
  • [Journal-full-title] Annales d'endocrinologie
  • [ISO-abbreviation] Ann. Endocrinol. (Paris)
  • [Language] fre
  • [Publication-type] Case Reports; English Abstract; Journal Article
  • [Publication-country] France
  • [Chemical-registry-number] 0 / Biomarkers; 9007-12-9 / Calcitonin; 971Z4W1S09 / Technetium Tc 99m Sestamibi
  •  go-up   go-down


60. Martínez Díaz-Guerra G, Hawkins Carranza F: [Concept, etiology and epidemiology of primary hyperparathyroidism]. Endocrinol Nutr; 2009 Apr;56 Suppl 1:2-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The incidence of PHPT rises with age, the mean age at diagnosis being 55 years.
  • This disorder affects mainly women with a female-to-male ratio of approximately 3:1.
  • Gene mutations affecting oncogenes (cyclin D1, RET) or tumor suppressor genes (MEN1, HRPT2) are found in a minority of cases.
  • These mutations are especially important in familial forms of PHPT, such as multiple endocrine neoplasia syndrome (MEN1, MEN2A).


61. Pack SD, Qin LX, Pak E, Wang Y, Ault DO, Mannan P, Jaikumar S, Stratakis CA, Oldfield EH, Zhuang Z, Weil RJ: Common genetic changes in hereditary and sporadic pituitary adenomas detected by comparative genomic hybridization. Genes Chromosomes Cancer; 2005 May;43(1):72-82
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Twenty-four pituitary adenomas, both the sporadic type (n = 18) and the type arising in association with either multiple endocrine neoplasia, type 1 (MEN1; n = 2), or Carney complex (CNC, n = 4) were analyzed by comparative genomic hybridization.
  • Chromosome 11 loss, which involved 11p in all cases, was the most significant finding and was common to tumors arising sporadically and in association with MEN1 and CNC.
  • In summary, all the tumors with chromosomal rearrangements (21 of 24, 88%), whether sporadic pituitary adenomas or those associated with MEN1 or CNC, had alteration(s) of 1p32, 11p, or 17.
  • [MeSH-major] Adenoma / genetics. Pituitary Neoplasms / genetics

  • MedlinePlus Health Information. consumer health - Pituitary Tumors.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2005 Wiley-Liss, Inc.
  • (PMID = 15704128.001).
  • [ISSN] 1045-2257
  • [Journal-full-title] Genes, chromosomes & cancer
  • [ISO-abbreviation] Genes Chromosomes Cancer
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DNA, Neoplasm
  •  go-up   go-down


62. Chen X, Zhang Y: Myocardial Cx43 expression in the cases of sudden death due to dilated cardiomyopathy. Forensic Sci Int; 2006 Oct 16;162(1-3):170-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULT: Of 11 cases of DCM, there were 10 men and 1 woman with ranging in age from 7 to 49 years old (x (37.8) years old for 9 adult cases).
  • Of 14 cases in the control group, there were 10 men and 4 women with ranging in age from 11 to 53 years old (x (29.9) years old for 11 adult cases).

  • Genetic Alliance. consumer health - Cardiomyopathy.
  • Genetic Alliance. consumer health - Dilated Cardiomyopathy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16887310.001).
  • [ISSN] 0379-0738
  • [Journal-full-title] Forensic science international
  • [ISO-abbreviation] Forensic Sci. Int.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Connexin 43
  •  go-up   go-down


63. Anlauf M, Enosawa T, Henopp T, Schmitt A, Gimm O, Brauckhoff M, Dralle H, Musil A, Hauptmann S, Perren A, Klöppel G: Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor. Am J Surg Pathol; 2008 Jul;32(7):1101-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Primary lymph node gastrinoma or occult duodenal microgastrinoma with lymph node metastases in a MEN1 patient: the need for a systematic search for the primary tumor.
  • We report on a 38-year-old woman suffering from multiple endocrine neoplasia type 1 (MEN1) confirmed by menin gene mutation analysis.
  • MEN1 disease started with primary hyperparathyroidism followed by Cushing disease, the detection of tumors of the pituitary, adrenal cortex, and the pancreas and also an elevated serum gastrin level.
  • In addition, 3 suprapancreatic lymph nodes with gastrin-positive endocrine tissue were found.
  • None of the pancreatic microadenomas expressed gastrin and no duodenal endocrine tumor was found despite careful macroscopic examination.
  • [MeSH-major] Duodenal Neoplasms / secondary. Gastrinoma / secondary. Lymph Nodes / pathology. Multiple Endocrine Neoplasia Type 1 / pathology. Neoplasms, Unknown Primary


64. Lobo A, Santos MP, Carvalho J: ["Physical fitness of institutionalized elderly: comparative analysis with reference values"]. Servir; 2008 Mar-Apr;56(2):74-9
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Transliterated title] "Aptidão física dos idosos afectados a instituições: Analise comparativa com os valores de referência".
  • This study reports: (i) men present better physical fitness;.

  • MedlinePlus Health Information. consumer health - Exercise and Physical Fitness.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19066163.001).
  • [ISSN] 0871-2379
  • [Journal-full-title] Servir (Lisbon, Portugal)
  • [ISO-abbreviation] Servir
  • [Language] por
  • [Publication-type] Comparative Study; English Abstract; Journal Article
  • [Publication-country] Portugal
  •  go-up   go-down


65. Matsushita S, Naito T, Takebayashi M, Sato H, Shiota H: The prognosis of cases with massive subretinal hemorrhage after photodynamic therapy. J Med Invest; 2008 Aug;55(3-4):231-5
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • SUBJECTS AND METHODS: We studied four cases (3 men and 1 woman, mean 80.5 years old) with massive subretinal hemorrhage after PDT about type of disease, spot size, period to the onset of hemorrhage, visual acuity (VA) before and after PDT.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18797136.001).
  • [ISSN] 1349-6867
  • [Journal-full-title] The journal of medical investigation : JMI
  • [ISO-abbreviation] J. Med. Invest.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


66. Ertem K, Kekilli KE, Yağmur C, Ayan I, Turgut S, Bostan H, Bora A: Somatotrophic reorganization in the brain after extremity replantation, revascularization and amputations: investigated by SPECT analysis. Ulus Travma Acil Cerrahi Derg; 2006 Apr;12(2):121-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Twelve patients (11 men, 1 female; mean age 38.9+/-14.7 years) and controls (5 men, mean age 32.2+/-7.9 years) were enrolled in this study.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16676251.001).
  • [ISSN] 1306-696X
  • [Journal-full-title] Ulusal travma ve acil cerrahi dergisi = Turkish journal of trauma & emergency surgery : TJTES
  • [ISO-abbreviation] Ulus Travma Acil Cerrahi Derg
  • [Language] eng
  • [Publication-type] Controlled Clinical Trial; Journal Article
  • [Publication-country] Turkey
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 3B744AG22N / Technetium Tc 99m Exametazime
  •  go-up   go-down


67. Cohen Aubart F, Barete S, Amoura Z, Francès C, Lyon-Caen O, Lebrun-Vignes B: Intravenous immunoglobulins-induced eczematous eruption: a long-term follow-up study. Eur J Intern Med; 2009 Jan;20(1):70-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: There were 8 men and 1 woman.
  • Seven patients were treated with intravenous immunoglobulins for neurological disease.
  • Switching the type of IVIg is often a useful strategy.

  • MedlinePlus Health Information. consumer health - Eczema.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19237096.001).
  • [ISSN] 1879-0828
  • [Journal-full-title] European journal of internal medicine
  • [ISO-abbreviation] Eur. J. Intern. Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Immunoglobulins, Intravenous; 0 / Steroids
  •  go-up   go-down


68. Katai M, Sakurai A, Uchino S, Minemura K, Hashizume K, Fukushima Y: Novel 14 base-pair deletion of the MEN1 gene in a patient with recurrent primary hyperparathyroidism. Jpn J Clin Oncol; 2006 Jun;36(6):395-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Novel 14 base-pair deletion of the MEN1 gene in a patient with recurrent primary hyperparathyroidism.
  • MEN1 is the causative gene for multiple endocrine neoplasia type 1 (MEN1), a hereditary syndrome characterized by hyperplastic and neoplastic disorder of endocrine organs such as parathyroid, anterior pituitary and gastroenteropancreatic endocrine tissues.
  • More than 300 germline mutations have already been reported in patients with MEN1.
  • Genetic testing revealed a heterozygous deletion involving 14 bp in exon 6 (starting at amino acid codon 293) of MEN1, which results in early termination of the protein.
  • [MeSH-major] Germ-Line Mutation. Hyperparathyroidism, Primary / genetics. Multiple Endocrine Neoplasia Type 1 / genetics. Parathyroid Glands / pathology. Proto-Oncogene Proteins / genetics
  • [MeSH-minor] Base Pairing. Female. Frameshift Mutation. Gene Deletion. Humans. Hypercalcemia / diagnosis. Hyperplasia. Middle Aged. Parathyroidectomy. Pedigree. Polymerase Chain Reaction. Recurrence

  • Genetic Alliance. consumer health - Hyperparathyroidism, primary.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16714299.001).
  • [ISSN] 0368-2811
  • [Journal-full-title] Japanese journal of clinical oncology
  • [ISO-abbreviation] Jpn. J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / MEN1 protein, human; 0 / Proto-Oncogene Proteins
  •  go-up   go-down


69. Domínguez Coello S, Cabrera de León A, Almeida González D, González Hernández A, Rodríguez Pérez MC, Fernández Ramos N, Brito Díaz B, Castro Fuentes R, Aguirre Jaime A: Inverse association between serum resistin and insulin resistance in humans. Diabetes Res Clin Pract; 2008 Nov;82(2):256-61
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • AIM: To determine how serum concentrations of resistin are distributed in humans in relation to insulin resistance, type 2 diabetes, and obesity.
  • METHODS: Cross-sectional, descriptive study carried out in a random sample (n=713, 43% men, 18-75 years) of general population of inhabitants of the Canary Islands (Spain).
  • Individuals with abdominal obesity (waist-hip ratio [WHR] >or=1 in men or >or=0.9 in women) had lower concentrations of resistin (3.0+/-0.13 vs. 3.4+/-0.1ng/mL; p<0.001).
  • The correlations between resistin and HOMA2-IR (r=-0.231; p<0.001) and between resistin and WHR (r=-0.202; p<0.001) were inverse.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18789551.001).
  • [ISSN] 1872-8227
  • [Journal-full-title] Diabetes research and clinical practice
  • [ISO-abbreviation] Diabetes Res. Clin. Pract.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] Ireland
  • [Chemical-registry-number] 0 / Resistin
  •  go-up   go-down


70. Sohn DS, Bae MS, Choi BJ, An KM, Shin HI: Efficacy of demineralized bone matrix paste for maxillary sinus augmentation: a histologic and clinical study in humans. Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 Nov;108(5):e30-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVES: The aim of this study is to report the effect of paste type of demineralized bone matrix (DBM) on augmentation of maxillary sinus using clinical parameters.
  • This study included 5 patients, 4 men and 1 woman, aged from 41 to 67 years (mean age 55 years).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19836711.001).
  • [ISSN] 1528-395X
  • [Journal-full-title] Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics
  • [ISO-abbreviation] Oral Surg Oral Med Oral Pathol Oral Radiol Endod
  • [Language] eng
  • [Publication-type] Clinical Trial; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Bone Substitutes
  •  go-up   go-down


71. Rozé V, Bresson JL, Fellmann F: Quantitative PCR technique for the identification of microrearrangements of the AZFc region. J Assist Reprod Genet; 2007 Jun;24(6):241-8
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Fourteen DNA controls were selected to validate the use of Q-PCR to detect AZFc microrearrangements, and sperm DNA samples from 30 fertile men were studied.
  • RESULTS: Rearrangements of 14 controls were well identified with Q-PCR, and 2 AZFc partial deletions were detected in fertile men (1 "gr-gr" and 1 "b2-b3").

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Med Genet. 2004 Nov;41(11):814-25 [15520406.001]
  • [Cites] Mol Hum Reprod. 2002 Mar;8(3):286-98 [11870237.001]
  • [Cites] Hum Reprod. 2005 Jan;20(1):216-20 [15513974.001]
  • [Cites] J Med Genet. 2005 Mar;42(3):209-13 [15744033.001]
  • [Cites] J Med Genet. 2005 Jun;42(6):497-502 [15937085.001]
  • [Cites] J Assist Reprod Genet. 2005 Apr;22(4):141-8 [16021857.001]
  • [Cites] Hum Reprod. 2005 Aug;20(8):2153-6 [15878928.001]
  • [Cites] Mol Hum Reprod. 2005 Jul;11(7):507-12 [16123079.001]
  • [Cites] Genomics. 2005 Oct;86(4):431-8 [16085382.001]
  • [Cites] Genomics. 2000 Aug 1;67(3):256-67 [10936047.001]
  • [Cites] Hum Mol Genet. 2000 Sep 22;9(15):2291-6 [11001932.001]
  • [Cites] Hum Hered. 2002;53(1):8-17 [11901266.001]
  • [Cites] Electrophoresis. 2002 Apr;23(7-8):1021-4 [11981848.001]
  • [Cites] Am J Hum Genet. 2002 Oct;71(4):906-22 [12297986.001]
  • [Cites] Hum Reprod. 2002 Nov;17(11):2813-24 [12407032.001]
  • [Cites] Fertil Steril. 2002 Dec;78(6):1209-14 [12477514.001]
  • [Cites] Mol Hum Reprod. 2003 Apr;9(4):183-8 [12651899.001]
  • [Cites] Nature. 2003 Jun 19;423(6942):825-37 [12815422.001]
  • [Cites] Nature. 2003 Jun 19;423(6942):873-6 [12815433.001]
  • [Cites] Nat Genet. 2003 Nov;35(3):247-51 [14528305.001]
  • [Cites] Am J Hum Genet. 2004 Jan;74(1):180-7 [14639527.001]
  • [Cites] Genomics. 2004 Jun;83(6):1046-52 [15177557.001]
  • [Cites] Mol Hum Reprod. 2004 Oct;10(10):755-61 [15347736.001]
  • [Cites] Hum Mol Genet. 1996 Jul;5(7):933-43 [8817327.001]
  • [Cites] J Clin Endocrinol Metab. 1999 Oct;84(10):3660-5 [10523011.001]
  • [Cites] Cytogenet Cell Genet. 2001;92(1-2):63-8 [11306798.001]
  • [Cites] Nat Genet. 2001 Nov;29(3):279-86 [11687796.001]
  • [Cites] Fertil Steril. 2002 Jan;77(1):68-75 [11779593.001]
  • [Cites] Hum Reprod. 2005 Jan;20(1):191-7 [15498781.001]
  • (PMID = 17410421.001).
  • [ISSN] 1058-0468
  • [Journal-full-title] Journal of assisted reproduction and genetics
  • [ISO-abbreviation] J. Assist. Reprod. Genet.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article; Validation Studies
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / DAZ1 protein, human; 0 / RNA-Binding Proteins
  • [Other-IDs] NLM/ PMC3454972
  •  go-up   go-down


72. Schmiedl S, Wesselmann U, Lehmann P, Haage P, Grebe SO: Different time courses of nephrogenic systemic fibrosis: Is there a role for pharmacokinetic aspects in explaining a new clinical entity? Int J Clin Pharmacol Ther; 2009 Nov;47(11):695-700
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PATIENTS' DETAILS: All 3 patients (2 men, 1 woman, aged 51 - 54 years) suffered from end-stage renal disease (ESRD) and were on long-term dialysis.
  • 1 of the patients received multiple therapies (e.g.
  • UV-A1 treatment, physical therapy) without significant improvement, 2 patients died from cardiac complications shortly after the diagnosis of NSF.

  • Genetic Alliance. consumer health - Nephrogenic Systemic Fibrosis.
  • MedlinePlus Health Information. consumer health - Kidney Failure.
  • Hazardous Substances Data Bank. GADOPENTETATE DIMEGLUMINE .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19840534.001).
  • [ISSN] 0946-1965
  • [Journal-full-title] International journal of clinical pharmacology and therapeutics
  • [ISO-abbreviation] Int J Clin Pharmacol Ther
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Contrast Media; 84F6U3J2R6 / gadodiamide; K2I13DR72L / Gadolinium DTPA
  •  go-up   go-down


73. Pyon JK, Park BJ, Mun GH, Cha MK, Lim SY, Bang SI, Oh KS: Endoscopic excision of cheek lipomas. Ann Plast Surg; 2008 Oct;61(4):413-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There were 7 men and 1 woman with a mean age of 34.8 years (range, 22-54 years).
  • [MeSH-major] Cheek / surgery. Endoscopy / methods. Facial Neoplasms / surgery. Lipoma / surgery

  • MedlinePlus Health Information. consumer health - Endoscopy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 18812713.001).
  • [ISSN] 1536-3708
  • [Journal-full-title] Annals of plastic surgery
  • [ISO-abbreviation] Ann Plast Surg
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


74. Plaza JA, Mayerson J, Wakely PE Jr: Nodular fasciitis of the hand: a potential diagnostic pitfall in fine-needle aspiration cytopathology. Am J Clin Pathol; 2005 Mar;123(3):388-93
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Nodular fasciitis, an uncommon pseudosarcomatous lesion of soft tissue, rarely occurs in the hand and, because of this, is not often considered in the differential diagnosis of hand masses.
  • We report 3 cases (2 men and 1 woman; mean age, 44.3 years) of soft tissue masses of the hand, which, after clinical and radiologic evaluation, were strongly suspected by an experienced orthopedic oncologist as harboring a soft tissue sarcoma.
  • Nodular fasciitis remains a difficult diagnosis by FNAB, particularly when it occurs in locations such as the hand.
  • [MeSH-major] Biopsy, Fine-Needle. Diagnostic Errors. Fasciitis / pathology. Hand / pathology. Sarcoma / pathology. Soft Tissue Neoplasms / pathology
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Humans. Male. Middle Aged

  • MedlinePlus Health Information. consumer health - Soft Tissue Sarcoma.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15716235.001).
  • [ISSN] 0002-9173
  • [Journal-full-title] American journal of clinical pathology
  • [ISO-abbreviation] Am. J. Clin. Pathol.
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


75. Cardascia N, Furino C, Ferrara A, Boscia F, Alessio G: Treatment of recurrent retinal angiomatous proliferation with intravitreal triamcinolone acetonide followed by photodynamic therapy with verteporfin: A retrospective case series. Curr Ther Res Clin Exp; 2009 Jun;70(3):240-51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Five patients (4 men, 1 woman; mean [SD] age, 76.8 [3.9] years) with 6 eyes diagnosed with stage II R-RAP who had previously been treated with PDT and who received an IVT injection and PDT within 1 month were included in the study.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 24683234.001).
  • [ISSN] 0011-393X
  • [Journal-full-title] Current therapeutic research, clinical and experimental
  • [ISO-abbreviation] Curr Ther Res Clin Exp
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Other-IDs] NLM/ PMC3967339
  • [Keywords] NOTNLM ; intravitreal triamcinolone acetonide / photodynamic therapy / retinal angiomatous proliferation
  •  go-up   go-down


76. Calender A, Groupe d'étude des Tumeurs Endocrines: [Multiple endocrine neoplasia: genetic aspects]. Bull Acad Natl Med; 2010 Jan;194(1):81-95; discussion 95-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Multiple endocrine neoplasia: genetic aspects].
  • Multiple endocrine neoplasia type 1 (MEN1) and type 2 (MEN2) are major genetic disorders carrying a high risk of endocrine tumor development.
  • The mutated genes were identified in 1993 (MEN2-RET) and 1997 (MEN1), enabling genetic testing and functional studies.
  • Genetic analysis has led to new clinical and therapeutic strategies for MEN1/2 patients, and has improved our understanding of the pathways underlying the development of such tumors, which occur in an autosomal dominant manner and with high penetrance.
  • The MEN1 gene encodes menin, a protein involved in many cell functions, such as transcription, genome stability, cell cycling and apoptosis.
  • The MEN1 gene has 10 exons, and its exhaustive analysis in MEN1 patients helps guide their management.
  • We also briefly describe the genetic basis of three other inherited states predisposing individuals to endocrine tumors, namely Carney's syndrome, hyperparathyroidism type 2 (HRPT2) and familial isolated pituitary adenoma (FIPA), which are related to inactivating mutations in the PRKAR1-alpha, HRPT2 and AIP genes, respectively.
  • [MeSH-major] Genes, Tumor Suppressor. Multiple Endocrine Neoplasia / genetics. Proto-Oncogene Proteins / genetics. Proto-Oncogene Proteins c-ret / genetics
  • [MeSH-minor] Animals. Carcinoma, Medullary / genetics. Carcinoma, Medullary / pathology. Digestive System Neoplasms / genetics. Dimerization. Disease Models, Animal. Embryonic Development / genetics. Female. Genes, Dominant. Genetic Testing. Glial Cell Line-Derived Neurotrophic Factor Receptors / chemistry. Glial Cell Line-Derived Neurotrophic Factor Receptors / metabolism. Humans. Mice. Mutation, Missense. Neoplastic Syndromes, Hereditary / genetics. Pregnancy. Protein Structure, Tertiary. Thyroid Neoplasms / genetics. Thyroid Neoplasms / pathology

  • Genetic Alliance. consumer health - Multiple Endocrine Neoplasia.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20669561.001).
  • [ISSN] 0001-4079
  • [Journal-full-title] Bulletin de l'Académie nationale de médecine
  • [ISO-abbreviation] Bull. Acad. Natl. Med.
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Netherlands
  • [Chemical-registry-number] 0 / Glial Cell Line-Derived Neurotrophic Factor Receptors; 0 / MEN1 protein, human; 0 / Proto-Oncogene Proteins; EC 2.7.10.1 / Proto-Oncogene Proteins c-ret; EC 2.7.10.1 / RET protein, human
  • [Number-of-references] 30
  •  go-up   go-down


77. Rubinstein WS: Endocrine cancer predisposition syndromes: hereditary paraganglioma, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, and hereditary thyroid cancer. Hematol Oncol Clin North Am; 2010 Oct;24(5):907-37
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine cancer predisposition syndromes: hereditary paraganglioma, multiple endocrine neoplasia type 1, multiple endocrine neoplasia type 2, and hereditary thyroid cancer.
  • The hereditary paraganglioma, MEN1, MEN2, and hereditary thyroid cancer syndromes are clinically discernable and genetically distinct.
  • Recognizing these 3 syndromes and using a multidisciplinary team approach creates valuable opportunities for early diagnosis, reduction of morbidity and mortality, and avoidance of surgical misadventures.
  • Hereditary paraganglioma has parent-of-origin effects and gene-environment interactions that indicate its evolution, and the syndrome sheds light on the role of mitochondria and energy metabolism in cancer.
  • This article delineates the clinical presentation and practical management issues and summarizes the history, gene discovery, and molecular insights for each syndrome.
  • [MeSH-major] Genetic Predisposition to Disease. Multiple Endocrine Neoplasia Type 1 / genetics. Multiple Endocrine Neoplasia Type 2a / genetics. Thyroid Neoplasms / genetics
  • [MeSH-minor] Diagnosis, Differential. Genetic Testing. Genomic Imprinting. Humans


78. McCallum RW, Parameswaran V, Burgess JR: Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose. Clin Endocrinol (Oxf); 2006 Aug;65(2):163-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Multiple endocrine neoplasia type 1 (MEN 1) is associated with an increased prevalence of diabetes mellitus and impaired fasting glucose.
  • OBJECTIVE: Multiple endocrine neoplasia type 1 (MEN 1) is an autosomal dominant syndrome characterized by primary hyperparathyroidism, pituitary neoplasia and foregut lineage neuroendocrine tumours.
  • As diabetes is a risk factor for increased cardiovascular mortality we investigated the prevalence and clinical correlates of glycaemic abnormalities in a large MEN 1 kindred.
  • PATIENTS AND DESIGN: The glycaemic status of 72 MEN 1 affected and 133 unaffected members of a single large MEN 1 pedigree was assessed.
  • Associations between glycaemic status and MEN 1 phenotype were assessed.
  • RESULTS: Thirteen (18.1%) patients with MEN 1 compared to 5 (3.8%) control patients were diabetic (P < 0.001).
  • Six (8.3%) MEN 1 patients had impaired fasting glucose compared to 4 (3%) of controls (P < 0.05).
  • Of patients with MEN 1, uncontrolled hypercalcaemia (P < 0.05) and elevated serum gastrin (P < 0.05) were more common amongst patients diagnosed with abnormal glycaemia than those with normoglycaemia.
  • There was a nonsignificant trend for elevated chromogranin A, pancreatic polypeptide, gastric inhibitory polypeptide (but not glucagon) and history of bronchopulmonary carcinoid in MEN 1 patients with elevated glycaemia.
  • CONCLUSIONS: Diabetes and impaired fasting glucose occur significantly more frequently amongst MEN 1 patients than controls and is associated with uncontrolled hyperparathyroidism and evidence of enteropancreatic hyperstimulation.
  • [MeSH-major] Blood Glucose / analysis. Diabetes Mellitus / diagnosis. Multiple Endocrine Neoplasia Type 1 / complications


79. Schöffl V, Hochholzer T, Schöffl I: Extensor hood syndrome--osteophytic irritation of digital extensor tendons in rock climbers. Wilderness Environ Med; 2010 Sep;21(3):253-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extensor hood syndrome--osteophytic irritation of digital extensor tendons in rock climbers.
  • METHODS: Thirteen high-level rock climbers (12 men, 1 woman; average age 33.8 years [range 17-55]; average years of climbing experience 19 [range 5-30]; average climbing level 10.2) with extensor hood irritation caused by dorsally located osteophytes of proximal interphalangeal (n = 10) or distal interphalangeal joints (n = 3) were evaluated and managed.
  • Extensor hood irritation must be considered in the differential diagnosis of finger pain in rock climbers.

  • MedlinePlus Health Information. consumer health - Finger Injuries and Disorders.
  • MedlinePlus Health Information. consumer health - Sports Injuries.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright 2010 Wilderness Medical Society. Published by Elsevier Inc. All rights reserved.
  • (PMID = 20832704.001).
  • [ISSN] 1545-1534
  • [Journal-full-title] Wilderness & environmental medicine
  • [ISO-abbreviation] Wilderness Environ Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


80. Luján M, Vigil A, Turo J, Pascual C, Nevado M, Martín C, Chiva V: The performance of vasectomy in an urban municipality. Practical considerations for follow-up. Arch Esp Urol; 2010 Nov;63(9):797-802
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Retrospective analysis of 391 men who underwent vasectomy.
  • After the first 6 months from surgery, 41.1%men still presented nonmotile rare sperm in semen analysis, 9.7% after 9 months, and 4.7% after 12 months.
  • If semen analysis was postponed from 6 to 9 months after surgery, a total yearly saving of 6,153.23 Euro would be observed in our setting, but with the drawback of delaying the diagnosis of azoospermia in nearly 60% of men.
  • CONCLUSIONS: The percentage of men not achieving azoospermia 6 months after surgery is notorious.

  • MedlinePlus Health Information. consumer health - Vasectomy.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 21098904.001).
  • [ISSN] 1576-8260
  • [Journal-full-title] Archivos españoles de urología
  • [ISO-abbreviation] Arch. Esp. Urol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Spain
  •  go-up   go-down


81. Sunmola AM, Olley BO, Oso GE: Predictors of condom use among sexually active persons involved in compulsory national service in Ibadan, Nigeria. Health Educ Res; 2007 Aug;22(4):459-72
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In July and August 2004, a survey was conducted on sexually active men (n = 344) and women (n = 373) to investigate determinants of condom use during national service.
  • Sixty-eight percent of men and 41% of women reported condom use at last intercourse before the survey.
  • For both men and women, condom use was common if they had one or more regular sex partners and if they were purchasing condoms.
  • The findings further showed that there was high risk of HIV transmission in the sample population as consistent condom use was 15% for men and 4% for women.
  • Twelve percent of men and 8% of women reported STI diagnoses in the last 12 months before the survey.
  • Four percent of men and 2% of women reported they already had HIV diagnoses.
  • Only 1% of men and 2% of women reported they would receive voluntary HIV test if offered free by the government.

  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16997898.001).
  • [ISSN] 0268-1153
  • [Journal-full-title] Health education research
  • [ISO-abbreviation] Health Educ Res
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


82. Korenromp MJ, Page-Christiaens GC, van den Bout J, Mulder EJ, Hunfeld JA, Potters CM, Erwich JJ, van Binsbergen CJ, Brons JT, Beekhuis JR, Omtzigt AW, Visser GH: A prospective study on parental coping 4 months after termination of pregnancy for fetal anomalies. Prenat Diagn; 2007 Aug;27(8):709-16
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • STUDY DESIGN: A prospective cohort of 217 women and 169 men completed standardized questionnaires 4 months after termination.
  • RESULTS: Women and men showed high levels of posttraumatic stress (PTS) symptoms (44 and 22%, respectively) and symptoms of depression (28 and 16%, respectively).
  • Whether the condition was Down syndrome or another disability was irrelevant to the outcome.
  • Only 2% of women and less than 1% of men regretted the decision to terminate.

  • Genetic Alliance. consumer health - Pregnancy.
  • MedlinePlus Health Information. consumer health - Depression.
  • MedlinePlus Health Information. consumer health - Post-Traumatic Stress Disorder.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2007 John Wiley & Sons, Ltd.
  • (PMID = 17533631.001).
  • [ISSN] 0197-3851
  • [Journal-full-title] Prenatal diagnosis
  • [ISO-abbreviation] Prenat. Diagn.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  •  go-up   go-down


83. Cernea S, Kidron M, Wohlgelernter J, Raz I: Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study. Clin Ther; 2005 Oct;27(10):1562-70
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dose-response relationship of an oral insulin spray in six patients with type 1 diabetes: a single-center, randomized, single-blind, 5-way crossover study.
  • OBJECTIVE: This study evaluated the pharmacokinetic and pharmacodynamic properties and dose-response effects of an oral insulin spray formulation compared with those of subcutaneously injected regular insulin and placebo in patients with type 1 diabetes mellitus.
  • METHODS: This was a single-center, randomized, single-blind, open-label, 5-way crossover study in which patients with type 1 diabetes received 5, 10, and 20 puffs of the oral insulin spray; regular insulin 0.1 U/kg SC; and placebo spray.
  • RESULTS: The study enrolled 6 white men with type 1 diabetes (mean [SD] age, 37.5 [16.2] years, mean weight, 82.7 [17.0] kg).
  • CONCLUSIONS: In this study in patients with type 1 diabetes, oral insulin spray had a faster onset and shorter duration of action than subcutaneously injected regular insulin.
  • [MeSH-major] Diabetes Mellitus, Type 1 / drug therapy. Hypoglycemic Agents / therapeutic use. Insulin / therapeutic use

  • Genetic Alliance. consumer health - Diabetes.
  • MedlinePlus Health Information. consumer health - Diabetes Medicines.
  • MedlinePlus Health Information. consumer health - Diabetes Type 1.
  • The Lens. Cited by Patents in .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16330292.001).
  • [ISSN] 0149-2918
  • [Journal-full-title] Clinical therapeutics
  • [ISO-abbreviation] Clin Ther
  • [Language] eng
  • [Publication-type] Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Aerosols; 0 / Blood Glucose; 0 / Hypoglycemic Agents; 0 / Insulin
  •  go-up   go-down


84. Klöppel G, Anlauf M, Perren A: Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors. Endocr Pathol; 2007;18(3):150-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Endocrine precursor lesions of gastroenteropancreatic neuroendocrine tumors.
  • There are three conditions that are associated with hyperplastic changes in endocrine cells preceding GEP-NETs: autoimmune chronic atrophic gastritis or multiple endocrine neoplasia type 1 (MEN1) with gastric enterochromaffin-like (ECL) cell hyperplasia; MEN1 with gastrin and somatostatin cell hyperplasia in the duodenum and glucagon cell hyperplasia in the islets of the pancreas; and inflammatory bowel disease with endocrine cell hyperplasia in the colon.
  • In gastric ECL cell hyperplasia, it is assumed that hypergastrinemia promotes the growth of the ECL cells of the corpus mucosa and leads to hyperplasia and neoplasia.
  • In the duodenum and the pancreas, the MEN1-associated germline mutation of the menin gene obviously causes hyperplasia of the gastrin and somatostatin cells (duodenum) and the glucagon cells (pancreas), resulting in multifocal development of tumors.
  • These tumors show allelic deletion of the MEN1 gene, whereas the precursor lesions retain their heterozygosity.
  • The endocrine cell hyperplasia in the colon described in inflammatory bowel disease has neither a genetic nor a definite hormonal background.
  • [MeSH-major] Gastrointestinal Neoplasms / pathology. Neuroendocrine Tumors / pathology. Pancreatic Neoplasms / pathology. Precancerous Conditions / etiology
  • [MeSH-minor] Biomarkers, Tumor / metabolism. Colonic Neoplasms / genetics. Colonic Neoplasms / metabolism. Colonic Neoplasms / pathology. Duodenal Neoplasms / genetics. Duodenal Neoplasms / metabolism. Duodenal Neoplasms / pathology. Humans. Models, Biological. Rectal Neoplasms / genetics. Rectal Neoplasms / metabolism. Rectal Neoplasms / pathology. Stomach Neoplasms / genetics. Stomach Neoplasms / metabolism. Stomach Neoplasms / pathology

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Cancer. 1991 Feb 1;67(3):663-72 [1702355.001]
  • [Cites] Gastroenterology. 2005 May;128(5):1187-98 [15887103.001]
  • [Cites] Gastroenterol Clin North Am. 1989 Dec;18(4):671-93 [2575601.001]
  • [Cites] Yale J Biol Med. 1996 Jan-Feb;69(1):69-74 [9041691.001]
  • [Cites] Am J Surg Pathol. 2006 Dec;30(12):1581-7 [17122515.001]
  • [Cites] Histopathology. 1992 Nov;21(5):487-8 [1452135.001]
  • [Cites] Digestion. 1988;41(4):185-200 [3072229.001]
  • [Cites] Yale J Biol Med. 1998 May-Aug;71(3-4):273-84 [10461358.001]
  • [Cites] Endocr Rev. 2005 Aug;26(5):615-61 [15632315.001]
  • [Cites] Science. 1997 Apr 18;276(5311):404-7 [9103196.001]
  • [Cites] J Clin Pathol. 2005 Jan;58(1):111-2; author reply 1112 [15623500.001]
  • [Cites] J Clin Pathol. 2003 Dec;56(12):963-5 [14645360.001]
  • [Cites] Am J Clin Pathol. 1992 Jul;98(1):112-6 [1615914.001]
  • [Cites] Gut. 1994 Feb;35(2):275-7 [8307483.001]
  • [Cites] Gut. 2007 May;56(5):637-44 [17135306.001]
  • [Cites] Gastroenterology. 1999 Mar;116(3):532-42 [10029611.001]
  • [Cites] Dig Dis Sci. 1995 Jun;40(6):1275-8 [7781446.001]
  • [Cites] World J Surg. 1984 Aug;8(4):561-74 [6207668.001]
  • [Cites] Dis Colon Rectum. 2004 Mar;47(3):387-91 [14991503.001]
  • [Cites] Digestion. 1995;56(6):455-62 [8536814.001]
  • [Cites] World J Gastroenterol. 2006 Sep 14;12(34):5440-6 [17006979.001]
  • [Cites] Cancer. 1986 May 1;57(9):1824-32 [2420439.001]
  • [Cites] N Engl J Med. 1990 Mar 15;322(11):723-7 [1968616.001]
  • [Cites] Gastroenterology. 1993 Apr;104(4):994-1006 [7681798.001]
  • [Cites] Cancer Res. 2000 Nov 15;60(22):6223-6 [11103773.001]
  • [Cites] Dis Colon Rectum. 1992 Jul;35(7):685-8 [1611958.001]
  • [Cites] J Clin Endocrinol Metab. 2004 Apr;89(4):1934-8 [15070966.001]
  • [Cites] J Clin Endocrinol Metab. 2007 Mar;92(3):1118-28 [17179192.001]
  • [Cites] Am J Surg Pathol. 1990 Jun;14(6):503-13 [1970928.001]
  • [Cites] Oncogene. 2001 Nov 22;20(53):7809-11 [11753660.001]
  • (PMID = 18058264.001).
  • [ISSN] 1046-3976
  • [Journal-full-title] Endocrine pathology
  • [ISO-abbreviation] Endocr. Pathol.
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Biomarkers, Tumor
  • [Number-of-references] 32
  •  go-up   go-down


85. Krassowski J: [Diagnostic and therapeutic difficulties in MEN 1 syndrome]. Endokrynol Pol; 2005 May-Jun;56(3):302-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Diagnostic and therapeutic difficulties in MEN 1 syndrome].
  • [Transliterated title] Trudności w rozpoznawaniu i leczeniu MEN 1.
  • MEN 1 syndrome (Multiple Endocrine Neoplasia type 1) is a rare endocrine disorder characterized by the association of tumors in several endocrine glands, mainly in parathyroids, gut and pituitary.
  • At our institution in the years 1982-2004 we have followed 26 patients with MEN 1 syndrome belonging to 19 families.
  • The diagnosis of MEN 1 was based on Gubbio Consensus (JCEM 86: 5658-5671, 2001).
  • Mean age at the diagnosis of MEN 1 was 35 years.
  • Gut endocrine tumors were found in 20 patients (77%), while pituitary tumors in 18 (70%).
  • Three patients died during the observation period - all of them of generalized gut endocrine tumor (gastrinoma in 2 cases and foregut carcinoid in one case).
  • The management of MEN 1 is not easy and careful analysis of clinical picture is necessary in each individual case.
  • In each sporadic pathology, which may be a part of MEN 1, one should consider. the possibility of MEN 1.
  • The individual MEN 1 abnormalities are often diagnosed after 40 and later 2.
  • MEN 1 tumor are usually multiple thus necessitating a different therapeutic approach (more radical surgery) 3.
  • Endoscopic ultrasound is the most specific method for the localization of pancreatic endocrine tumors.
  • 5. The results of surgical treatment of MEN 1 tumors are worse than that of sporadic tumors.
  • 6. Prognosis in MEN 1 is determined by the behaviour of gut neuroendocrine tumor 7.
  • No genotype/phenotype correlation in MEN 1 syndrome was found so far.
  • In summary, it should be underlined that MEN 1 syndrome is an endocrine disorder, in which early diagnosis and optimal treatment may significantly improve the prognosis.
  • [MeSH-major] Multiple Endocrine Neoplasia Type 1 / diagnosis. Multiple Endocrine Neoplasia Type 1 / therapy
  • [MeSH-minor] Adult. Diagnosis, Differential. Female. Follow-Up Studies. Gastrinoma / diagnosis. Gastrinoma / therapy. Humans. Intestinal Neoplasms / diagnosis. Intestinal Neoplasms / therapy. Male. Middle Aged. Neoplasm Staging. Pancreatic Neoplasms / diagnosis. Pancreatic Neoplasms / therapy. Pituitary Neoplasms / diagnosis. Pituitary Neoplasms / therapy. Retrospective Studies. Risk Factors. Stomach Neoplasms / diagnosis. Stomach Neoplasms / therapy

  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16350723.001).
  • [ISSN] 0423-104X
  • [Journal-full-title] Endokrynologia Polska
  • [ISO-abbreviation] Endokrynol Pol
  • [Language] pol
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Poland
  • [Number-of-references] 12
  •  go-up   go-down


86. Ellison EC, Sparks J, Verducci JS, Johnson JA, Muscarella P, Bloomston M, Melvin WS: 50-year appraisal of gastrinoma: recommendations for staging and treatment. J Am Coll Surg; 2006 Jun;202(6):897-905
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Gastrinoma is a rare neuroendocrine tumor associated with ulcerogenic syndrome.
  • Patients were classified as sporadic gastrinoma (SG) or MEN.
  • End points of analysis included disease-free and disease-specific survival.
  • Surgical resection was possible in 72 patients (SG, n = 50; MEN, n = 22).
  • Durable cure rate for SG was 26%, compared with 4% for MEN-1.
  • Surgical resection achieving gross removal of all tumor resulted in improved survival in both SG and MEN patients (p < 0.0001).
  • In the management of gastrinoma, it is recommended that SG and MEN patients with clinical stage I and II disease have surgical exploration, patients with stage III disease not have mandatory surgical treatment, and some stage 0 patients might not need routine surgical exploration.
  • [MeSH-major] Gastrinoma. Pancreatectomy / standards. Pancreatic Neoplasms. Practice Guidelines as Topic
  • [MeSH-minor] Disease-Free Survival. Female. Follow-Up Studies. Humans. Male. Middle Aged. Neoplasm Recurrence, Local / epidemiology. Neoplasm Staging / standards. Ohio / epidemiology. Retrospective Studies. Survival Rate / trends. Time Factors

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16735203.001).
  • [ISSN] 1072-7515
  • [Journal-full-title] Journal of the American College of Surgeons
  • [ISO-abbreviation] J. Am. Coll. Surg.
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


87. Kuyper LM, Lampinen TM, Chan K, Miller ML, Schilder A, Hogg RS: Similar sexual behaviors with casual partners among gay men with and without a regular partner. Sex Transm Dis; 2005 Mar;32(3):203-5
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Similar sexual behaviors with casual partners among gay men with and without a regular partner.
  • OBJECTIVES: We hypothesized that men in a relationship would engage in less risky sexual activity with their casual partners compared to men with only casual partners.
  • STUDY: Cross-sectional data were collected between 1999 and 2003 in a study of young human immunodeficiency virus-seronegative gay men in Vancouver, British Columbia.
  • We assessed the substance use and sexual behaviors of 156 men and compared those having casual partners in addition to 1 regular partner for the duration of the previous year (n = 43) to those reporting only casual partners during the previous year (n = 113).
  • RESULTS: Men with just 1 regular partner were not significantly different from men without a regular partner with regard to sexual behaviors reportedly engaged in with casual partners, self-reported sexually transmitted infections diagnosed within the previous year, or demographic characteristics.
  • Only previous use of poppers and higher frequencies of marijuana use were found among men without a regular partner.
  • CONCLUSIONS: In our cohort, young gay men in a relationship do not appear less likely to engage in risky sex with casual partners than men with casual partners only.

  • MedlinePlus Health Information. consumer health - Sexually Transmitted Diseases.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 15729161.001).
  • [ISSN] 0148-5717
  • [Journal-full-title] Sexually transmitted diseases
  • [ISO-abbreviation] Sex Transm Dis
  • [Language] eng
  • [Publication-type] Journal Article; Research Support, Non-U.S. Gov't
  • [Publication-country] United States
  •  go-up   go-down


88. Ito T, Sasano H, Tanaka M, Osamura RY, Sasaki I, Kimura W, Takano K, Obara T, Ishibashi M, Nakao K, Doi R, Shimatsu A, Nishida T, Komoto I, Hirata Y, Nakamura K, Igarashi H, Jensen RT, Wiedenmann B, Imamura M: Epidemiological study of gastroenteropancreatic neuroendocrine tumors in Japan. J Gastroenterol; 2010 Feb;45(2):234-43
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: We examined the epidemiology of GEP-NETs [pancreatic endocrine tumors (PETs) and gastrointestinal neuroendocrine tumors (GI-NETs)] in Japan in 2005 using a nationwide stratified random sampling method.
  • Multiple endocrine neoplasia type 1 (MEN-1) was detected in 10% of PETs but only in 6.1% of NF-PETs.
  • The frequency of MEN-1 complications was 1%.
  • Interestingly, 77.1% of patients with foregut GI-NETs had type A gastritis.
  • CONCLUSION: Our results show there are large differences in GEP-NETs between Japan and Western nations, primarily due to differences in the presence of MEN-1 in NF-PETs and the location, symptomatic status, and prevalence of malignancy in GI-NETs.
  • [MeSH-major] Gastrointestinal Neoplasms / epidemiology. Neuroendocrine Tumors / epidemiology. Pancreatic Neoplasms / epidemiology

  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Neuroendocrinology. 2004;80(6):394-424 [15838182.001]
  • [Cites] Int J Cancer. 2008 Aug 15;123(4):867-73 [18491401.001]
  • [Cites] Ann Oncol. 2008 May;19(5):903-8 [18209014.001]
  • [Cites] J Gastroenterol. 2007 Jun;42(6):497-500 [17671766.001]
  • [Cites] J Clin Oncol. 2008 Jun 20;26(18):3063-72 [18565894.001]
  • [Cites] Gastroenterology. 1968 Dec;55(6):677-86 [4302500.001]
  • [Cites] Ann Oncol. 2001 Sep;12(9):1295-300 [11697843.001]
  • [Cites] Br J Cancer. 2000 Oct;83(7):952-5 [10970700.001]
  • [Cites] Oncology (Williston Park). 2008 Dec;22(14):1617-23; discussion 1623-4, 1629 [19198220.001]
  • [Cites] Br J Surg. 2000 Feb;87(2):129-31 [10671915.001]
  • [Cites] Dig Liver Dis. 2004 Feb;36 Suppl 1:S106-20 [15077919.001]
  • [Cites] Acta Pathol Microbiol Scand A. 1976 Jul;84(4):322-30 [961424.001]
  • [Cites] Acta Oncol. 2004;43(7):626-36 [15545183.001]
  • [Cites] World J Surg. 2006 May;30(5):654-62; discussion 663-4 [16680582.001]
  • [Cites] J Clin Gastroenterol. 2006 Aug;40(7):572-82 [16917396.001]
  • [Cites] Cancer. 2005 Apr 15;103(8):1587-95 [15742328.001]
  • [Cites] Endocr Relat Cancer. 2005 Dec;12(4):1083-92 [16322345.001]
  • [Cites] World J Surg. 1996 Feb;20(2):168-72 [8661813.001]
  • [Cites] Gut. 1973 Jul;14(7):549-51 [4729922.001]
  • [Cites] Cancer. 2008 Jul 15;113(2):256-65 [18506737.001]
  • [Cites] Cancer. 2003 Feb 15;97(4):934-59 [12569593.001]
  • [Cites] N Engl J Med. 1999 Mar 18;340(11):858-68 [10080850.001]
  • [Cites] Neuroendocrinology. 2006;83(5-6):380-6 [17016032.001]
  • [Cites] Gastroenterology. 2008 Nov;135(5):1469-92 [18703061.001]
  • [Cites] Acta Oncol. 2004;43(7):617-25 [15545182.001]
  • [Cites] Expert Rev Anticancer Ther. 2003 Dec;3(6):863-77 [14686708.001]
  • [Cites] Gastroenterology. 1997 Feb;112(2):335-47 [9024287.001]
  • [Cites] Endocr Relat Cancer. 2008 Dec;15(4):1083-97 [18603570.001]
  • [Cites] J Am Coll Surg. 2008 Dec;207(6):874-81 [19183534.001]
  • [Cites] Radiology. 1993 Apr;187(1):129-33 [8383865.001]
  • [Cites] Eur J Surg Oncol. 1997 Feb;23(1):36-42 [9066745.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):753-81 [16253899.001]
  • [Cites] J Exp Clin Cancer Res. 1999 Jun;18(2):133-41 [10464698.001]
  • [Cites] Lancet Oncol. 2008 Jan;9(1):61-72 [18177818.001]
  • (PMID = 20058030.001).
  • [ISSN] 1435-5922
  • [Journal-full-title] Journal of gastroenterology
  • [ISO-abbreviation] J. Gastroenterol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  •  go-up   go-down


89. Martin IE, Tsang RS, Sutherland K, Anderson B, Read R, Roy C, Yanow S, Fonseca K, White W, Kandola K, Kouadjo E, Singh AE: Molecular typing of Treponema pallidum strains in western Canada: predominance of 14d subtypes. Sex Transm Dis; 2010 Sep;37(9):544-8
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Four molecular subtypes were identified, with one type, 14d, accounting for 70% of all cases and 83% of typeable strains.
  • Seven patients (16%) were found to be infected by macrolide-resistant strains, of which 6 were men who have sex with men and 1 whose infection was acquired in China.
  • CONCLUSIONS: A single molecular type of T. pallidum, characterized as 14d, caused the majority of the syphilis cases identified in this study.

  • MedlinePlus Health Information. consumer health - Syphilis.
  • COS Scholar Universe. author profiles.
  • Hazardous Substances Data Bank. AZITHROMYCIN .
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 20539263.001).
  • [ISSN] 1537-4521
  • [Journal-full-title] Sexually transmitted diseases
  • [ISO-abbreviation] Sex Transm Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents; 0 / DNA, Bacterial; 0 / Macrolides; 83905-01-5 / Azithromycin
  •  go-up   go-down


90. Kianmanesh R, O'toole D, Sauvanet A, Ruszniewski P, Belghiti J: [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors]. J Chir (Paris); 2005 May-Jun;142(3):132-49
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] [Surgical treatment of gastric, enteric, and pancreatic endocrine tumors Part 1. Treatment of primary endocrine tumors].
  • Endocrine tumors (ET) of the digestive tract (formerly called neuroendocrine tumors) are rare.
  • Ileal ET's, even if small, are malignant, frequently multiple, and complicated in 30-50% of cases by bowel obstruction, mesenteric invasion, or bleeding.
  • The carcinoid syndrome (consisting of abdominal pain, flushing, diarrhea, hypertension, bronchospasm, and right sided cardiac vegetations) is caused by the hypersecretion of serotonin into the systemic circulation; it occurs in 10% of cases and is usually associated with hepatic metastases.
  • They are usually malignant and of advanced stage at diagnosis presenting as a palpable or obstructing mass or as liver metastases.
  • Insulinoma and gastrinoma (cause of the Zollinger-Ellison syndrome) are the most common functional ET's. 80% are sporadic; in these cases, tumor size, location, and malignant potential determine the type of resection which may vary from a simple enucleation to a formal pancreatectomy.
  • In 10-20% of cases, pancreaticoduodenal ET presents in the setting of multiple endocrine neoplasia (NEM type I), an autosomal-dominant genetic disease with multifocal endocrine involvement of the pituitary, parathyroid, pancreas, and adrenal glands.
  • For insulinoma with NEM-I, enucleation of lesions in the pancreatic head plus a caudal pancreatectomy is the most appropriate procedure.
  • For gastrinoma with NEM-I, the benefit of surgical resection for tumors less than 2-3 cm in size is not clear.
  • The lesions are frequently small, multiple, and widespread and recurrence is frequent after excision.
  • But the eventual development of liver metastases which are the most common cause of mortality still argues for an aggressive surgical approach in the early stages of the disease.
  • [MeSH-major] Carcinoid Tumor / surgery. Carcinoma, Islet Cell / surgery. Carcinoma, Neuroendocrine / surgery. Insulinoma / surgery. Intestinal Neoplasms / surgery. Multiple Endocrine Neoplasia Type 1 / surgery. Pancreatic Neoplasms / surgery. Stomach Neoplasms / surgery. Zollinger-Ellison Syndrome / surgery
  • [MeSH-minor] Adult. Gastrinoma / diagnosis. Gastrinoma / surgery. Glucagonoma / diagnosis. Glucagonoma / surgery. Humans. Liver Neoplasms / secondary. Lymphatic Metastasis. Malignant Carcinoid Syndrome / diagnosis. Malignant Carcinoid Syndrome / surgery. Multicenter Studies as Topic. Pancreatectomy. Postoperative Care. Postoperative Complications. Prognosis. Somatostatinoma / diagnosis. Somatostatinoma / surgery. Vipoma / diagnosis. Vipoma / surgery

  • MedlinePlus Health Information. consumer health - Carcinoid Tumors.
  • MedlinePlus Health Information. consumer health - Pancreatic Cancer.
  • MedlinePlus Health Information. consumer health - Stomach Cancer.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16142076.001).
  • [ISSN] 0021-7697
  • [Journal-full-title] Journal de chirurgie
  • [ISO-abbreviation] J Chir (Paris)
  • [Language] fre
  • [Publication-type] Comparative Study; English Abstract; Journal Article; Review
  • [Publication-country] France
  • [Number-of-references] 236
  •  go-up   go-down


91. Scacheri PC, Davis S, Odom DT, Crawford GE, Perkins S, Halawi MJ, Agarwal SK, Marx SJ, Spiegel AM, Meltzer PS, Collins FS: Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis. PLoS Genet; 2006 Apr;2(4):e51
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Genome-wide analysis of menin binding provides insights into MEN1 tumorigenesis.
  • Multiple endocrine neoplasia type I (MEN1) is a familial cancer syndrome characterized primarily by tumors of multiple endocrine glands.
  • The gene for MEN1 encodes a ubiquitously expressed tumor suppressor protein called menin.
  • Menin was recently shown to interact with several components of a trithorax family histone methyltransferase complex including ASH2, Rbbp5, WDR5, and the leukemia proto-oncoprotein MLL.
  • To elucidate menin's role as a tumor suppressor and gain insights into the endocrine-specific tumor phenotype in MEN1, we mapped the genomic binding sites of menin, MLL1, and Rbbp5, to approximately 20,000 promoters in HeLa S3, HepG2, and pancreatic islet cells using the strategy of chromatin-immunoprecipitation coupled with microarray analysis.
  • Our findings expand the realm of menin-targeted genes several hundred-fold beyond that previously described and provide potential insights to the endocrine tumor bias observed in MEN1 patients.

  • COS Scholar Universe. author profiles.
  • Faculty of 1000. commentaries/discussion - See the articles recommended by F1000Prime's Faculty of more than 8,000 leading experts in Biology and Medicine. (subscription/membership/fee required).
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • SciCrunch. ArrayExpress: Data: Microarray .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Hum Genet. 2000 May;66(5):1504-15 [10749657.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 11;102(41):14659-64 [16195383.001]
  • [Cites] J Med Genet. 2000 Aug;37(8):561-6 [10922380.001]
  • [Cites] Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1118-23 [11158604.001]
  • [Cites] Cancer Res. 2001 Jul 15;61(14):5374-7 [11454678.001]
  • [Cites] Nat Genet. 2002 Jan;30(1):41-7 [11731795.001]
  • [Cites] Dev Biol. 2001 Dec 1;240(1):247-53 [11784060.001]
  • [Cites] Genes Dev. 2002 Jan 15;16(2):245-56 [11799067.001]
  • [Cites] Cancer Cell. 2002 Feb;1(1):75-87 [12086890.001]
  • [Cites] Nucleic Acids Res. 2003 Feb 15;31(4):e15 [12582260.001]
  • [Cites] Mol Cell Biol. 2003 Sep;23(17):6075-85 [12917331.001]
  • [Cites] Mol Endocrinol. 2003 Sep;17(9):1880-92 [12819299.001]
  • [Cites] Cancer Res. 2003 Aug 15;63(16):4836-41 [12941803.001]
  • [Cites] Genes Dev. 2003 Sep 15;17(18):2298-307 [12952893.001]
  • [Cites] Mol Cell Biol. 2004 Jan;24(2):617-28 [14701735.001]
  • [Cites] Blood. 2004 Mar 1;103(5):1823-8 [14615372.001]
  • [Cites] Science. 2004 Feb 27;303(5662):1378-81 [14988562.001]
  • [Cites] Mol Cell. 2004 Feb 27;13(4):587-97 [14992727.001]
  • [Cites] Mol Cell Biol. 2004 Apr;24(8):3125-31 [15060136.001]
  • [Cites] Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6062-7 [15075390.001]
  • [Cites] Mol Cell Biol. 2004 Jul;24(13):5639-49 [15199122.001]
  • [Cites] Am J Hum Genet. 2000 Jan;66(1):312-9 [10631160.001]
  • [Cites] Cancer Res. 2004 Oct 1;64(19):7039-44 [15466197.001]
  • [Cites] Proc Natl Acad Sci U S A. 1971 Apr;68(4):820-3 [5279523.001]
  • [Cites] Nat Genet. 1997 Aug;16(4):375-8 [9241276.001]
  • [Cites] Cancer Res. 1997 Nov 1;57(21):4682-6 [9354421.001]
  • [Cites] Hum Mol Genet. 1997 Dec;6(13):2285-90 [9361035.001]
  • [Cites] Cancer Res. 1997 Dec 15;57(24):5446-51 [9407947.001]
  • [Cites] Proc Natl Acad Sci U S A. 1998 Feb 17;95(4):1630-4 [9465067.001]
  • [Cites] J Clin Endocrinol Metab. 1998 Aug;83(8):2627-30 [9709922.001]
  • [Cites] Nat Genet. 1999 Sep;23(1):67-70 [10471501.001]
  • [Cites] Nat Genet. 1999 Sep;23(1):71-5 [10471502.001]
  • [Cites] Neuron. 1999 Aug;23(4):659-74 [10482234.001]
  • [Cites] Genes Chromosomes Cancer. 2005 Feb;42(2):170-8 [15540222.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Jan 18;102(3):749-54 [15640349.001]
  • [Cites] Mamm Genome. 2004 Nov;15(11):872-7 [15672591.001]
  • [Cites] Cell. 2005 Jan 28;120(2):169-81 [15680324.001]
  • [Cites] Endocrinology. 2005 Mar;146(3):1025-34 [15604203.001]
  • [Cites] Horm Metab Res. 2005 Jun;37(6):369-74 [16001329.001]
  • [Cites] Mol Cell Biol. 2000 Aug;20(16):6147-58 [10913196.001]
  • (PMID = 16604156.001).
  • [ISSN] 1553-7404
  • [Journal-full-title] PLoS genetics
  • [ISO-abbreviation] PLoS Genet.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / K25 DK070813; United States / NIDDK NIH HHS / DK / R01 DK068655; United States / Intramural NIH HHS / / ; United States / NIDDK NIH HHS / DK / K25-DK070813; United States / NIDDK NIH HHS / DK / R01-DK068655
  • [Publication-type] Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Homeodomain Proteins; 0 / MEN1 protein, human; 0 / MLL protein, human; 0 / MNX1 protein, human; 0 / Nuclear Proteins; 0 / Proto-Oncogene Proteins; 0 / RBBP5 protein, human; 0 / Transcription Factors; 149025-06-9 / Myeloid-Lymphoid Leukemia Protein; EC 2.1.1.43 / Histone-Lysine N-Methyltransferase
  • [Other-IDs] NLM/ PMC1428788
  •  go-up   go-down


92. Kaplitt MG, Feigin A, Tang C, Fitzsimons HL, Mattis P, Lawlor PA, Bland RJ, Young D, Strybing K, Eidelberg D, During MJ: Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial. Lancet; 2007 Jun 23;369(9579):2097-105
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Safety and tolerability of gene therapy with an adeno-associated virus (AAV) borne GAD gene for Parkinson's disease: an open label, phase I trial.
  • BACKGROUND: Dopaminergic neuronal loss in Parkinson's disease leads to changes in the circuitry of the basal ganglia, such as decreased inhibitory GABAergic input to the subthalamic nucleus.
  • We aimed to measure the safety, tolerability, and potential efficacy of transfer of glutamic acid decarboxylase (GAD) gene with adeno-associated virus (AAV) into the subthalamic nucleus of patients with Parkinson's disease.
  • METHODS: We did an open label, safety and tolerability trial of unilateral subthalamic viral vector (AAV-GAD) injection in 11 men and 1 woman with Parkinson's disease (mean age 58.2, SD=5.7 years).
  • Efficacy measures included the Unified Parkinson's Disease Rating Scale (UPDRS), scales of activities of daily living (ADL), neuropsychological testing, and PET imaging with 18F-fluorodeoxyglucose.
  • INTERPRETATION: AAV-GAD gene therapy of the subthalamic nucleus is safe and well tolerated by patients with advanced Parkinson's disease, suggesting that in-vivo gene therapy in the adult brain might be safe for various neurodegenerative diseases.
  • [MeSH-major] Activities of Daily Living. Dependovirus. Genetic Therapy / methods. Glutamate Decarboxylase / genetics. Parkinson Disease / therapy


93. Uysal T, Amasyali M, Ozcan S, Sagdic D: Demineralization properties of newly erupted and mature premolars around orthodontic brackets: an in-vivo study. Am J Orthod Dentofacial Orthop; 2010 May;137(5):582.e1-6; discussion 582-3
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Group 2 contained 6 adults with mature teeth (5 men, 1 woman; mean age, 34.64 +/- 4.01 years; range, 25-41 years).
  • RESULTS: ANOVA showed statistically significant differences for tooth type, position, depth, and their interactions (P <0.05), except the tooth type and position interaction.
  • The multiple comparison test showed less demineralization in the enamel around orthodontic brackets bonded to mature teeth campared with newly erupted teeth (P <0.05).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright (c) 2010 American Association of Orthodontists. Published by Mosby, Inc. All rights reserved.
  • (PMID = 20451770.001).
  • [ISSN] 1097-6752
  • [Journal-full-title] American journal of orthodontics and dentofacial orthopedics : official publication of the American Association of Orthodontists, its constituent societies, and the American Board of Orthodontics
  • [ISO-abbreviation] Am J Orthod Dentofacial Orthop
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Composite Resins; 0 / Resin Cements; 0 / Transbond XT; 0 / Transbond XT Light Cure Adhesive Primer
  •  go-up   go-down


94. DiMarco AF, Kowalski KE, Geertman RT, Hromyak DR, Frost FS, Creasey GH, Nemunaitis GA: Lower thoracic spinal cord stimulation to restore cough in patients with spinal cord injury: results of a National Institutes of Health-Sponsored clinical trial. Part II: clinical outcomes. Arch Phys Med Rehabil; 2009 May;90(5):726-32
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • PARTICIPANTS: Subjects (N=9; 8 men, 1 woman) with cervical spinal cord injury.

  • MedlinePlus Health Information. consumer health - Cough.
  • MedlinePlus Health Information. consumer health - Spinal Cord Injuries.
  • ClinicalTrials.gov. clinical trials - ClinicalTrials.gov .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] JAMA. 1980 Feb 8;243(6):528-31 [7351783.001]
  • [Cites] Am Rev Respir Dis. 1967 Oct;96(4):666-77 [6057606.001]
  • [Cites] Muscle Nerve. 1986 Feb;9(2):104-26 [2936955.001]
  • [Cites] N Engl J Med. 1986 Mar 20;314(12):740-4 [3951503.001]
  • [Cites] Paraplegia. 1987 Jun;25(3):262-6 [3601438.001]
  • [Cites] J Neurophysiol. 1987 Sep;58(3):598-613 [3655884.001]
  • [Cites] J Appl Physiol (1985). 1989 Mar;66(3):1143-51 [2708239.001]
  • [Cites] Ann Intern Med. 1990 Jan 1;112(1):22-8 [2293817.001]
  • [Cites] J Appl Physiol (1985). 1992 Apr;72(4):1393-400 [1317372.001]
  • [Cites] J Appl Physiol (1985). 1992 Apr;72(4):1401-6 [1534322.001]
  • [Cites] Chest. 1993 Nov;104(5):1553-62 [8222823.001]
  • [Cites] Paraplegia. 1993 Dec;31(12):793-9 [8115172.001]
  • [Cites] Arch Phys Med Rehabil. 1994 Mar;75(3):270-5 [8129577.001]
  • [Cites] Am J Respir Crit Care Med. 1995 May;151(5):1466-71 [7735601.001]
  • [Cites] Spinal Cord. 1997 Feb;35(2):76-85 [9044513.001]
  • [Cites] Spinal Cord. 1998 Apr;36(4):266-74 [9589527.001]
  • [Cites] Arch Phys Med Rehabil. 1998 Aug;79(8):900-9 [9710160.001]
  • [Cites] Arch Phys Med Rehabil. 1999 Aug;80(8):877-84 [10453762.001]
  • [Cites] J Rehabil Res Dev. 2005 May-Jun;42(3 Suppl 1):87-110 [16195966.001]
  • [Cites] Respir Care. 2006 Aug;51(8):853-68;discussion 869-70 [16867197.001]
  • [Cites] J Spinal Cord Med. 2006;29(5):511-9 [17274490.001]
  • [Cites] Am J Phys Med Rehabil. 2007 May;86(5):387-96 [17449983.001]
  • [Cites] J Spinal Cord Med. 2007;30(4):307-8 [17853651.001]
  • [Cites] J Spinal Cord Med. 2007;30(4):319-30 [17853653.001]
  • [Cites] J Spinal Cord Med. 2007;30(4):355-61 [17853657.001]
  • [Cites] Respir Care. 2007 Oct;52(10):1296-305; discussion 1306-7 [17894900.001]
  • [Cites] Arch Phys Med Rehabil. 1999 Nov;80(11):1411-9 [10569435.001]
  • [Cites] Thorax. 2001 Jun;56(6):438-44 [11359958.001]
  • [Cites] Qual Health Res. 2001 Nov;11(6):795-811 [11710078.001]
  • [Cites] Spinal Cord. 2002 Jul;40(7):341-50 [12080462.001]
  • [Cites] Eur Respir J. 2003 Mar;21(3):502-8 [12662009.001]
  • [Cites] Thorax. 1967 Jan;22(1):88-96 [6031920.001]
  • [Cites] Am J Phys Med. 1984 Feb;63(1):1-10 [6703028.001]
  • (PMID = 19406290.001).
  • [ISSN] 1532-821X
  • [Journal-full-title] Archives of physical medicine and rehabilitation
  • [ISO-abbreviation] Arch Phys Med Rehabil
  • [Language] eng
  • [Databank-accession-numbers] ClinicalTrials.gov/ NCT00116337
  • [Grant] United States / NCRR NIH HHS / RR / UL1 RR024989; United States / NCRR NIH HHS / RR / UL1 RR024989-025927; United States / NCRR NIH HHS / RR / M01 RR00080; United States / NINDS NIH HHS / NS / R01 NS049516; United States / NINDS NIH HHS / NS / R01 NS049516-04; United States / NCRR NIH HHS / RR / M01 RR000080-436226; United States / NCRR NIH HHS / RR / M01 RR000080
  • [Publication-type] Clinical Trial; Comparative Study; Journal Article; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Other-IDs] NLM/ NIHMS165573; NLM/ PMC2809374
  •  go-up   go-down


95. Muñoz-Muñiz FE, Zamorano-Echavarría F, Martínez-Torres J, Garrido-Amieva ME: [Level of knowledge of the family physician about preventive stomatology]. Rev Med Inst Mex Seguro Soc; 2006 Jan-Feb;44(1):83-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • RESULTS: Sample with an average age of 44 years old +/- 6.8; 44 of them (63%) were men, proportion of 2:1 men/1 woman; 42 of them (60%) had a good level of knowledge.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16497266.001).
  • [ISSN] 0443-5117
  • [Journal-full-title] Revista médica del Instituto Mexicano del Seguro Social
  • [ISO-abbreviation] Rev Med Inst Mex Seguro Soc
  • [Language] spa
  • [Publication-type] English Abstract; Journal Article
  • [Publication-country] Mexico
  •  go-up   go-down


96. Seki R, Seki H, Toyama T, Koyama K, Endo K, Kurabayashi M: Practical assessment of myocardial viability with a positron coincidence gamma camera using 18F-fluorodeoxyglucose in acute myocardial infarction: comparison with dedicated positron emission tomography and 201Tl single photon emission computed tomography. J Cardiol; 2009 Apr;53(2):265-71
PDF icon [Fulltext service] Download fulltext PDF of this article and others, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A total of 15 patients (14 men and 1 woman, mean age: 60+/-7 years, range: 46-73) with a large acute myocardial infarction (AMI) underwent (18)F-FDG PET, (18)F-FDG PCD imaging after oral glucose loading (75 g) and (201)Tl SPECT imaging.

  • MedlinePlus Health Information. consumer health - Heart Attack.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 19304132.001).
  • [ISSN] 1876-4738
  • [Journal-full-title] Journal of cardiology
  • [ISO-abbreviation] J Cardiol
  • [Language] eng
  • [Publication-type] Comparative Study; Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Thallium Radioisotopes; 0Z5B2CJX4D / Fluorodeoxyglucose F18
  •  go-up   go-down


97. Liu CF, Kung CT, Liu BM, Ng SH, Huang CC, Ko SF: Splenic artery aneurysms encountered in the ED: 10 years' experience. Am J Emerg Med; 2007 May;25(4):430-6
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: A retrospective survey of our ED database revealed 7 cases of SAA (6 men, 1 woman; mean age, 56 years) of 651,347 ED visits over the last decade.
  • CONCLUSIONS: In the ED, ruptured SAA should be included as a rare differential consideration of acute abdomen, especially in middle-aged men with liver cirrhosis and portal hypertension.
  • Although SAA may be an unexpected computed tomographic finding, once diagnosed, endovascular treatment is recommended.
  • [MeSH-major] Aneurysm / diagnosis. Aneurysm / therapy. Emergency Service, Hospital / statistics & numerical data. Splenic Artery
  • [MeSH-minor] Abdomen, Acute / etiology. Adult. Aged. Aneurysm, Ruptured / complications. Aneurysm, Ruptured / diagnosis. Aneurysm, Ruptured / therapy. Female. Follow-Up Studies. Humans. Male. Middle Aged. Radiography, Abdominal. Retrospective Studies. Rupture, Spontaneous. Shock / etiology. Taiwan. Treatment Outcome

  • MedlinePlus Health Information. consumer health - Aneurysms.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17499662.001).
  • [ISSN] 1532-8171
  • [Journal-full-title] The American journal of emergency medicine
  • [ISO-abbreviation] Am J Emerg Med
  • [Language] eng
  • [Publication-type] Case Reports; Journal Article
  • [Publication-country] United States
  •  go-up   go-down


98. Yoo JC, Ahn JH, Yoon JR, Yang JH: Clinical results of single-tunnel coracoclavicular ligament reconstruction using autogenous semitendinosus tendon. Am J Sports Med; 2010 May;38(5):950-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Between August 2005 and January 2008, a total of 21 patients, 16 patients (14 men, 2 women) with a Rockwood type IV, type V, or a chronic type III acromioclavicular (AC) dislocation and 5 patients (4 men, 1 woman) with a painful nonunited distal clavicle fracture with CC separation, underwent CC reconstructive surgery using a semitendinosus autograft.
  • Chronic type III AC dislocations and nonunited distal clavicle fractures with CC separation were scored using preoperative AC scoring (AC Joint Separation Questionnaire).
  • CONCLUSION: Single-tunnel CC reconstruction with an autogenous hamstring tendon graft after a mean follow-up of 33 months (range, 18-47) appears to be a satisfactory means of treating acute Rockwood type IV, V, chronic type III, and painful nonunited distal clavicle fractures with CC separation.


99. Daghfous R, El Aidli S, Gheni R, Belkahia C: [Drug tendon disorders]. Tunis Med; 2005 May;83(5):253-7
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In three cases, tendinitis was described with statines, and concerned 2 men and 1 woman, aged more than 50 years.

  • MedlinePlus Health Information. consumer health - Statins.
  • MedlinePlus Health Information. consumer health - Tendinitis.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 16044896.001).
  • [ISSN] 0041-4131
  • [Journal-full-title] La Tunisie médicale
  • [ISO-abbreviation] Tunis Med
  • [Language] fre
  • [Publication-type] English Abstract; Journal Article; Review
  • [Publication-country] Tunisia
  • [Chemical-registry-number] 0 / Adrenal Cortex Hormones; 0 / Fluoroquinolones; 0 / Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • [Number-of-references] 28
  •  go-up   go-down


100. Ergün EL, Kara PO, Gedik GK, Kars A, Türker A, Caner B: The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions. Ann Nucl Med; 2007 Jul;21(5):275-83
PDF icon [Fulltext service] Get downloadable fulltext PDFs of articles closely matching to this article, as many as you want.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
  • METHODS: Tc-99m (V) DMSA whole-body scans, planar thorax views, and thorax Single-photon emission computed tomography (SPECT) images were obtained both 30 min (early) and 5 h (late) after Tc-99m (V) DMSA administration in 12 small/nonsmall cell LC patients (11 men, 1 woman; mean age 59 years).
  • [MeSH-major] Carcinoma, Non-Small-Cell Lung / diagnosis. Carcinoma, Non-Small-Cell Lung / radionuclide imaging. Carcinoma, Small Cell / diagnosis. Carcinoma, Small Cell / radionuclide imaging. Lung Neoplasms / diagnosis. Lung Neoplasms / radionuclide imaging. Radiopharmaceuticals / pharmacology. Technetium Tc 99m Dimercaptosuccinic Acid / pharmacology. Tomography, Emission-Computed, Single-Photon / methods

  • Genetic Alliance. consumer health - Lung Cancer.
  • MedlinePlus Health Information. consumer health - Lung Cancer.
  • COS Scholar Universe. author profiles.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 17634845.001).
  • [ISSN] 0914-7187
  • [Journal-full-title] Annals of nuclear medicine
  • [ISO-abbreviation] Ann Nucl Med
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Japan
  • [Chemical-registry-number] 0 / Radiopharmaceuticals; 494JNQ8L28 / Technetium Tc 99m Dimercaptosuccinic Acid
  •  go-up   go-down






Advertisement